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Abstract
Drosophila Robo2 axon guidance receptor is a member of the evolutionarily conserved
Roundabout (Robo) protein family that is involved in directing axons that cross the midline to
the other side of the animal body. Robo2 roles mainly depend on two factors: The functional
domains of the Robo2 protein, which is extensively studied, and the dynamic transcription of
robo2 in various subsets of cells throughout embryogenesis which is not fully understood. Thus,
knowing robo2 enhancers that transcriptionally regulate robo2 during embryogenesis is
significant. To investigate robo2 potential enhancers, we screened 17 transgenic lines of
Drosophila that were generated by Janelia Research Center. These lines contain 17 fragments
distributed within and around the robo2 gene. We identified six fragments that regulated robo2
expression by the GAL4-UAS-GFP system suggesting that they were promising enhancers.
Using these identified regulatory fragments in addition to three fragments generated in our lab,
we built the HA-Robo2 transgenic constructs. These constructs were introduced into Drosophila
which allowed us to test robo2 expression and its dependent axon guidance phenotypes in the
embryonic CNS. GMR28G05 and GMR28F02 fragments showed the strongest robo2 expression
in the lateral pathway. To further study these fragments, we introduced them separately or
together into robo2 null mutant background. We found that Robo2’s dynamic expression pattern
is specified by multiple regulatory regions.
We utilized these fragments to generate and characterize an equivalent set of robo2
transgenes expressing the axonal marker TauMyc instead of the HA-Robo2 and hsp70 promoter
instead of robo2 promoter. The results show that GMR28F02 fragment drove strong expression
of TauMyc in a subset of the lateral neurons, cell bodies, and commissural axon from which
Robo2 protein is expressed.

CRISPR/Cas9 system was used to further investigate the importance of our findings.
Cas9 protein and specific gRNAs were used to target and delete robo2 potential enhancers
(GMR28G05 and GMR28F02) separately or together. Applying bioinformatics tools and
literature I predicted three transcription factors (Hb9, Nkx6.1, and Lhx2) that have a high
probability to bind robo2 potential enhancers.
In summary, robo2 has potential enhancers located in the first intron and upstream of the
gene, and multiple enhancers more efficiently regulated robo2 expression in Drosophila.
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Chapter one: Axon Guidance role in the central nervous system (CNS) of Drosophila
melanogaster and Roundabout2 protein
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Introduction
Significance
Animals with bilateral symmetry sense and respond to their environment through their
nervous system (Comer et al., 2019). During the nervous system development, the formation of
a network between neuronal and non-neuronal cells is one of the most interesting processes. The
key step in this process is the axons that extend precisely towards their desired synaptic targets.
Researchers have extensively studied this phenomenon a few decades ago using cellular and
molecular mechanisms controlling the navigation and neuronal growth (Dickson & Zou, 2010;
Hidalgo & Booth, 2000; Sáchez-Soriano et al., 2007; Raper & Mason, 2010; Tessier-Lavigne &
Goodman, 1996). Neuronal circuit development is orchestrated by axon guidance molecules such
as slit, the repellent ligand of the roundabout receptor (Robo), and netrin-1 which induces
attraction by frazzled receptor (DCC in vertebrates). Individuals with CNS limitation show
defects in the proteins engaged in axon guidance decisions. For example, a heterozygous
mutation in DCC causes congenital mirror movements disorder. Individuals with this kind of
disorder miss the ability to move both sides of the body independently, and this rare issue
persists throughout the patient’s life (Galléa et al., 2011). Also, Robo1 disruption is implicated
in communication disorder with dyslexia, a disorder characterized by trouble with reading,
spelling, and pronouncing words, and writing. This disruption is caused by chromosome
translocation in dyslexic individuals (Hannula-Jouppi et al., 2005). Moreover, Robo2/Slit2
disorder has been involved in the vesicoureteral reflux (VUR), a complex, genetically
heterogeneous developmental disorder described by the retrograding flow of urine from the
bladder into the ureter (Lu et al., 2007). Furthermore, a homozygous mutation in the human
robo3 gene located on chromosome 11 causes horizontal gaze palsy with progressive scoliosis
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(HGPPS) (Amoiridis et al., 2006). This mutation causes the hindbrain axons to fail to cross the
midline. Individuals with Horizontal gaze palsy develop scoliosis within the first ten years of
their life. (Nugent et al., 2012)
The human brain consists of around 100 billion neurons with 10,000 different cell types
that have different functions such as sensory neurons, motor cells, and memory cells, making
humans the most complex organism (Herculano-Houzel, 2009; Muotri & Gage, 2006). Despite
being different anatomically, smaller organisms such as Drosophila still share several conserved
cellular and genetic properties with humans (Venken et al., 2011). Being less complex than
humans, Drosophila was utilized as one of the most powerful model organisms in biomedical
science for more than a decade. The cheap, short generation time, a huge amount of progeny, and
very advanced genetic tools have made Drosophila requisite for biological research (Tolwinski,
2017). All these qualities in Drosophila encouraged the researchers to use it as a model to obtain
novel insight into the tools and mechanisms that can assist to suggest new treatments for various
neurological diseases (Ugur et al., 2016).
Development of the CNS in Drosophila
The early development of Drosophila CNS involves the differentiation of neuroblasts.
Neuroblasts are produced first by splitting from a neuro-ectoderm that is housed in the
ventrolateral section of the Drosophila embryo. They start dividing to form neurons and glia.
These neuroblasts keep dividing to generate another neuroblast and ganglion mother cell (GMC).
The latter (GMC) divides only one time to give rise to neurons and glial cells, the two essential
cell types build up the CNS (McDonald et al., 1998; Homem & Knoblich, 2012). While neurons
have two processes: axons and dendrites synapsis, glial cells have only one process and no
synapsis. In Drosophila melanogaster, the CNS contains two types of glial cells, midline glia
3

(MG) cells, and the lateral glia. MG cells are a subclass of neuropile glia that are expressed in the
early stage of embryogenesis and reduced during the pupal stage just before turning to adult fly
(Awad & Truman, 1997). They play a crucial role in embryonic signaling and wrapping the
axons that cross the CNS. Once connect to the adjacent neurons, MG cells get access to perform
multiple tasks, such as migration, ensheathment, subdivision of axon commissures, apoptosis,
and extension of glial processes. MG cells in Drosophila are functionally and morphologically
akin to mammalian floorplate cells (Crews, 2010) making the midline an essential point to
orchestrate axon pathfinding (Crews, 2010; Kaprielian et al., 2001).
Axon guidance
Information is transferred between the two halves of the nervous system through
commissures, which consist of neurons that extend axons across the midline to the other side of
the CNS. While some axons cross the midline once, others such as ipsilateral axons never cross
the midline. Instead, they extend exclusively on their own side of the CNS (Rajagopalan, Nicolas
et al., 2000). At the beginning of the differentiation, neurons eject multiple projections called
neurites. However, only one of these neurites develops an axon. Neurons send out their axons to
reach their destination to make synaptic connections with other neuronal and non-neuronal cells.
These axons can extend over very short or very long distances. So, for the axons to reach their
long-distance targets, they should grow to attain this goal. The previous studies proposed two
approaches for the axons to grow. The first approach suggests that axon pathways are broken
into shorter intervals or segments of about a hundred micrometers long. These segments act as
intermediate targets that the axons regulate the navigation by providing information that guides
the axons to grow along the next segment of the trajectory (Kaprielian et al., 2001). The second
approach for the axon extension to a long-distance proposes that pioneer axons that project early
4

in the developing neurons pave the way for the later-developing axons to track the same way that
the early axons established to reach their final destination (Tessier-Lavigne & Goodman, 1996).
Now that these approaches simplified the task of axons navigation through a long-distance by
having the long axons divided into short intervals, the question remains as to how these short
intervals of axons are formed? Genetic tools, tissue culture studies, and embryological
experiments show that there are four types of cues or molecules that axons respond to: shortrange attractants, short-range repellents, long-range attractants (chemoattractants), and longrange repellents (chemorepellents). Roman Y. Cajal was the first one who discovered the
growing tips of the axons about one hundred years ago. He anticipated that chemoattractant
might mediate axon guidance decision when he proposed that target cells release chemoattractant
substances to attract axons over a distance in a process similar to the chemotaxis in attracting
motile cells to their targets in a response to a diffusible chemoattractant substance from the target
cells (Figure 1.1).
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Figure 1.1. Four types of guidance forces associated with guiding growth cones:
contact attraction, chemoattraction, contact repulsion, and chemorepulsion. (Top left
and right), netrin ligand that is involved in both chemoattraction and chemorepulsion
mechanisms. (Bottom, right), contact repulsion represented by Ephrin ligands,
transmembrane semaphorins and extracellular membrane (ECM). (Bottom, left),
adhesion molecules represented by immunoglobulins, cadherins, and ECMs. Adapted
from (Tessier-Lavigne & Goodman, 1996).
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Axon guidance molecules
Axons traverse through their environment in which different signaling molecules are
displayed on or secreted into the interstitial space of extracellular matrix by neuronal and nonneuronal cells. These molecules are represented by adhesive molecules, trophic molecules,
modulatory factors, tropic factors, and differentiation and morphogenic factors (Raper & Mason,
2010) (Figure 1.2).
A. Adhesive factors
For the axons to be protruded in their environment, they need suitable substrates called
adhesive factors. There are two major types of adhesive cues: extracellular matrix (ECM)
constituents, which are expressed on basement membrane or cellular interstices, and cell
adhesion molecules (CAMs) expressed on neuronal and non-neuronal surfaces. Adhesive cells
assist physical contact with the substrate required for axon extension. Laminin and fibronectin
are two examples of adhesion molecules in the ECM, and cadherins and immunoglobulin family
are two other examples of adhesion molecules on the cell surfaces (Raper & Mason, 2010).
B. Trophic signals
These signal molecules enhance axon outgrowth, the motility of growth cones, and
neuronal survival (Reichardt, 2006); Connolly et al., 1985). In vitro axonal outgrowth can be
affected by the neurotrophins concentration. When they get closer to their targets, neurotrophins
can behave as short-range attractants (Letourneau, 1978; Gundersen & Barrett, 1979).
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C. Modulatory cues
These are signaling molecules that are not attractants or repellants on their own.
However, they act by modulating the effectiveness of other guidance cues (Raper & Mason,
2010). For instance, even though these cues are not tropic, they can affect the way the axons
respond to the tropic cues. Chemokines, such as stromal cell-derived factor 1(SDF1) and
Laminin are examples of these types of cues. So, SDF1, or neurotrophins, for example, can
reduce the axon response to the repellent Semaphorin 3A even though they are not
Semaphorines on their own (Dontchev & Letourneau, 2002).
D. Tropic cues
This category of cues involves the chemotactic cues hypothesized by Roman Y. Cajal.
The major roles of these cues are attraction and repulsion. These cues are responsible for creating
remarkable changes in growth cone motility by influencing the cytoskeleton through intracellular
signaling. Examples of these cues are netrins, semaphorins, ephrins, and slits (Luo et al., 1993;
Renzi et al., 2000)
D.1. Netrins: They are secreted proteins that can act as both repellent and attractant in axon
guidance in the midline depending on their binding to particular receptors, such as unc-40 and
unc-5 that encode the conserved transmembrane proteins (Culotti & Merz, 1998). During
neurogenesis, netrins can act as either long- or short-range signals.
D.2. Semaphorins: Unlike netrins, semaphorins such as semaphorin 3A, is a secreted repellent
that prevents the growing of axons from inappropriate regions. In addition to being axon
guidance repellents, semaphorins act as short-range inhibitory signals. Due to their existence in
the scar tissue, class 3 semaphorins play a crucial role in central nervous system injuries such as
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axonal regrowth, re-vascularisation, re-myelination, and the immune response (Mecollari et al.,
2014).
D.3. Ephrins: They are a family of membrane-bound proteins that act as ligands of Eph
receptors. Signaling of Eph/ephrin leads to the regulation of multiple biological events during
embryonic development, such as cell migration, the building of tissue boundaries, segmentation,
and axon guidance of growth cones. During adulthood, ephrins play a role in some processes like
angiogenesis and stem cell differentiation. Based on their structure and binding to the cell
membrane, ephrin ligands fall into two subclasses: ephrin-A and ephrin B. Eph receptors, in turn,
are divided into two types ephAs and ephBs depending on their affinity to bind ephrin-A or
ephrin B ligands (Nomenclature & Ligands, 1997).
D.4. Slit: It is a secreted extracellular matrix protein that plays an active role in neuronal
development. The major function of Slit protein is acting as midline repellent by deflecting the
longitudinal axons from crossing the midline of CNS. It also participates in preventing
commissural axons from re-crossing the midline. The canonical receptor for Slit is Robo
transmembrane proteins. In vertebrates, slit is produced by the cells in the floor plates, while in
insects, including Drosophila, slit protein is produced by midline glia. Pioneer axon guidance
depends mainly on Slit/Robo signaling (Farmer et al., 2008).
E. Morphogenic and differentiation factors
These are signaling molecules that stimulate the cells to produce specific responses according
to their local concentration. During the early development, morphogens are produced as
gradients by specific cells and release through the tissue around these cells. These gradients are
responsible for driving the differentiation of stem cells into different cell types. Eventually,
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forming all the body tissues and organs. The majority of morphogens are secreted proteins that
act as signaling molecules between the cells. However, some of them diffuse in the
early embryonic stages such as transcription factors in Drosophila melanogaster.
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Figure 1.2. Axon guidance impacted by environmental cues: Different signaling
molecules are released or displayed on the surface of the neuronal and non-neuronal
cells where axons moving through. These molecules include morphogenic and
differentiation factors that play important role in neurons determination, trophic,
adhesive, modulatory, and tropic factors that affect the growth cones based on the
guidance receptors and signaling components found in the growth cone. Growth
cones motility is affected by signaling pathway resulted from specific guidance cues
and according to these signaling pathways growth cones, eventually respond
differently by pausing, collapsing, withdrawing, turning, or fasciculation with
different axons. This image is adapted from (Raper & Mason, 2010).
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Growth cones
During the nervous system development, the neuronal network establishment requires
extending the axons toward their suitable postsynaptic target cells. The process of extending
neurons to their axons occurs at the growth cones of the axons distal tips (Dent et al., 1999; Dent
& Gertler, 2003; Lowery & Vactor, 2009; Sánchez-Soriano et al., 2010). Growth cones are large
extensions developing or regenerating neurites looking for their appropriate synaptic targets
supported by actin (Vitriol & Zheng, 2012). The morphology of growth cones looks like a
human hand, it consists of two types of cytoskeletal elements which, in turn, lies in two regions,
the organelle-rich central domain, which consists of microtubules, and the organelle-poor
peripheral domain where actin filaments predominate and form two types of extensions:
filopodia and lamellipodia. Filopodia are fine and pointed extensions, they are also called
microspikes. They consist of bundles of actin filaments (F-actin) that provide the growth cones
with support and shape. Filopodia are bound by a membrane rich with receptors and cell
adhesion molecules which are necessary for axon growth and guidance. Unlike filopodia,
lamellipodia are flat regions of actin meshwork. lamellipodia are located between two filopodia.
Due to their quite dynamic merits, growth cones can respond to the surrounding environmental
stimuli by branching towards the stimuli and switching their directions (Dent & Gertler,
2003)(Figure 1. 3).

12

Figure 1.3. Neuronal growth cone. Growth cone is the motile human hand-like structure
that navigate through the environment in response to specific cues. It consists of two
cytoskeletal elements, which are distributed in two regions, the C region represents
organelle-rich central domain, which involves microtubules that extend to the base of
the filopodia, and P region that represents the organelle-poor peripheral domain where
actin filaments predominate forming filopodia and lamellipodia. This figure is adapted
from (Mueller, 1999).
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Robo family
Drosophila genome screen for mutant genes that play a key role in axon guidance
revealed the discovery of a special group of proteins called a roundabout. Roundabout or Robo is
a family of transmembrane protein receptors that are highly conserved among many animal taxa.
This family obtained its name (roundabout) from the circular-like traffic junctions, a phenotype
that resulted from axon crossing and improperly re-crossing the midline in Drosophila robo
mutant (Evans & Bashaw, 2012; Kidd et al., 1998). Robo receptors play a pivotal role in
nervous system development. Phylogenetic analysis shows that Robo receptors have developed
from certain ancestral proteins with multiple variations occurred over time in various lineages.
The robo gene was first discovered in Drosophila and has been cloned in different species such
as humans and mice. In invertebrates, such as Drosophila, the Robo family consists of three
Robo receptor members: Robo1, Robo2, and Robo3. (Rajagopalan, Vivancos et al., 2000;
Simpson, Kidd et al., 2000). Whereas in vertebrates, such as humans, the Robo family consists
of four Robo receptors: Robo1, Robo2, Robo3/Rig-1, and Robo4/magic roundabout. In
Drosophila, robo1 is located on chromosome 2R while robo2 and robo3 are located on the left
arm of the second chromosome (2L). In humans, robo1 and robo2 are located on chromosome
3p123, while robo3 and robo4 are placed on chromosome 11 p24.2.
Robo protein structure
Drosophila Robo family three members (Robo1, Robo2, and Robo3) share a 5+3
conserved ectodomain protein structure of five immunoglobulin-like (Ig) domains and three
fibronectin type III-like domains (FN). The cytoplasmic portion in Robo2 and Robo3 is shorter
and consists of only two cytodomains (CC0, and CC1), while Robo1 consists of four
cytodomains (CC0, CC1, CC2, and CC3). The cytoplasmic motifs of the Robo family are
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required for interactions with downstream effectors. (Kidd et al., 1998; Bashaw et al., 2000)
(Figure 1.4).
Robo2
Robo2 is a transmembrane protein that belongs to an evolutionarily conserved protein
family called a roundabout. This family plays an active role in axon guidance. As a
transmembrane protein, Robo2 structure includes mainly extracellular portion consists of five
immunoglobulin-like domains and three fibronectin-like repeats, transmembrane, and a
cytoplasmic domain made up of two cytoplasmic conserved motifs (CC0 and CC1). During the
early stages of axon trajectory, Robo2 is expressed in the ipsilateral pioneer axon where it
mediates midline repulsion. Robo2 also inhibits slit Robo1 repulsion by being expressed in the
midline cells. So, Robo2 promotes midline crossing (Evans et al., 2015). Furthermore, Robo2 is
expressed in the lateral regions of the neuropile in the late stages of nerve cord development to
enhance the formation of longitudinal axon pathways. The distinct roles of Robo2 depend in part
on different functional domains within its receptor protein, and on its dynamic expression in
different subsets of cells during embryogenesis in another part. Robo2 Ig1 domain is the
canonical Slit ligand-binding domain, which is essential for midline repulsion. Ig1 and Ig3
domains of Robo2 affect Robo2’s ability to control the lateral positions of longitudinal axons
while the Ig2 domain is required for promoting midline crossing (Evans & Bashaw, 2010b).
RNA seq data show that Drosophila Robo2 is expressed at a high-level in CNS and imaginal
disc. In Drosophila, robo2 expression levels are more likely organ-dependents. Studies showed
that robo2 has moderate expression in the fat body while it has a low expression in the head,
salivary gland, digestive system, testis, and accessory gland. Like robo2 expression in
Drosophila, robo2 expression in humans is organ dependent. It has been found that Robo2 was
15

expressed in a high level in the fetal brain, endocrine tissues, lung, kidney, urinary bladder, and
lower in bone marrow, salivary gland, thyroid gland, skin, adipose and soft tissues, pancreas,
liver, gall bladder, gastrointestinal tract, eye, and muscle tissue. (Yue et al., 2006; Sasaki et al.,
2020)
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Robo2

Repulsion

Nerve cell

Leucine-rich

Immunoglobulin (Ig)-like

Epidermal growth factor-like

Fibronectin type I (FnI)

Laminin G (LG)

Conserved cytoplasmic

C-terminal cysteine knot-like

Figure 1.4.A schematic shows three robo family members (Robo1, Robo2,
and Robo3) each of which consists of the 5+3 conserved ectodomain,
transmembrane domain, and cytodomains, which are two in both of Robo2
and Robo3(CC0, and CC1)), and four motifs in Robo1(CC0, CC1, CC2, and
CC3). Slit binds to the first immunoglobulin-like domain (Ig1) of the robo
receptors to activate axon guidance repulsion.
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The expression patterns and mutant phenotypes of the Drosophila Robo family
All Robo proteins are expressed in the embryonic CNS during the period of axon
outgrowth. Kidd et al., 1998a shows that Robo1 is expressed in the CNS during the formation of
the pathways in a consistent pattern. While Robo2 is expressed transiently during the
embryogenesis stages, Robo2 is extensively expressed during stage 12. However, its expression
becomes more restricted at later stages to a specific cell subset. Robo3, in turn, is the last Robo
family to be expressed in the CNS. It starts its expression at stage 13 of embryogenesis and this
expression is restricted to a subset of cells since the beginning of its expression. Compared to
robo2, robo3 shows more expression than robo2 in the later stages of embryogenesis. While
robo1 and robo2 show a high degree of similarity in their expression patterns in the periphery,
robo3 shows different peripheral expressions. robo3 is exclusively expressed in PNS neurons,
while robo2 is expressed in the epidermis as stripes in addition to the developing trachea, dorsal
vessel, and muscles.
All Robos are highly expressed in the longitudinal growth cones. However, their
expression is very low in the commissural growth cones. By the end of the developmental
embryogenesis, each one of the three Robos emerges in a particular pattern. For example, Robo1
is expressed in the entire width of the longitudinal tracts, robo2 shows expression on axons in the
lateral two-thirds, and Robo2 is expressed on axons in the lateral one-third of the longitudinal
tracts (Figure 1.5). According to their expression patterns, the three Robos divide the
longitudinal tracts into three zones: a medial zone, which consists of only robo1 expression, an
intermediate zone composed of both robo1 and robo3, and a lateral zone, which consists of all
the three Robos (Rajagopalan, Vivancos et al., 2000).
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Robo1 plays a major role in regulating axon guidance in the midline. In robo1 mutant, axons
cross the midline repeatedly without staying at the midline each time they cross it (Simpson,
Kidd et al., 2000) (Figure 1.6, B). In robo2 mutants, the lateral longitudinal pathway merges into
the intermediate pathway in addition to the defect this mutation causes in the midline crossing
represented by crossing some axons the midline at a level lower than the one that has seen in
robo1 mutant (Figure 1.6, C). In robo3 mutants, the intermediate longitudinal pathway shows
shifting medially to be fused with the medial pathway. However, the mutant phenotype does not
show any midline crossing in robo3 mutant (Figure 1.6, D) (Rajagopalan, Vivancos et al.,
2000).

19

Figure 1. 5. Robo1, Robo2, and Robo3 partition the longitudinal tract into three zones.
Stage 12 to early stage 13 of Drosophila CNS of wild type embryos. robo1 and robo2
share the same pattern of expression at stage early 13 with high level of protein expression
in the longitudinal pathway (arrow) and no protein detectable on axons of the growth
cones of commissure (arrowhead). The second panel shows Robo3 in older embryos than
Robo1 and Robo2 panels. The expression of robo3 is very low at this stage. At later
stages of embryogenesis robo2 becomes more restricted to be expressed in fewer axons
but its expression pattern is still close to Robo1. Robo3 is more detectable in stage 14.
Stage 16 shows the three robos expression in the longitudinal pathways in three distinct
but overlapping lateral zones. (Adapted from (Rajagopalan, Vivancos, et al., 2000)).
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1

robo2

robo3

Figure 1.6. robo mutants. A. Wild type Drosophila embryo at stage 16 stained by antiFasII antibody 1D4 shows FasII three longitudinal pathways on each side of the midline.
B. robo1 mutant shows ectopic crossing and re-crossing the midline by medial FasII
pathway. However, the intermediate and lateral pathways are not affected by this mutation
and they are more resemble to the wild type. C. robo2 mutant. The lateral pathway (the
third fascicle) fused with the second pathway (the intermediate) (arrows) and arrowhead
shows the midline crossing. D. robo3 mutant embryo shows shifting of the second
pathway (arrowheads) to be merged with the medial pathway (arrows) and there is no
midline crossing. (A and B images adapted from (Simpson, Kidd et al., 2000), and C and
D adapted from (Rajagopalan, Vivancos et al., 2000).
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Chapter Two: Transcriptional regulation of the robo2 gene in the Drosophila
Central Nervous System (CNS)
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Abstract
Robo2 is a transmembrane protein that regulates three distinct roles in directing axon
guidance in Drosophila central nervous system (CNS). These various roles of Robo2 depend in
part on its distinct functional domains and on the dynamic transcription in different subsets of
cells through embryogenesis in another part. The Robo2 structural and functional domains in
Drosophila were studied extensively in the previous years. However, little is known about the
transcriptional regulation of robo2. This chapter focuses on testing multiple regulatory regions
around the robo2 gene that represent potential enhancers for robo2. We utilized 17 transgenic
lines generated by Janelia GAL4 research campus in addition to three transgenic lines generated
in our lab where each transgenic line possesses one of the potential enhancers (fragments) of
robo2. Two of these fragments (GMR28GO5 and GMR28FO2) drove strong expression of
robo2 in subsets of the lateral pathway of the Drosophila’s Ventral Nerve Cord (VNC), while the
other two fragments (GMR28B05 and GMR28E07) enhanced robo2 expression in the midline
glia. Noticeably, individual fragments were not sufficient to fully rescue robo2 expression in
robo2 null mutant background. Although one of these fragments (GMR28G05) rescued the
midline repulsion of the robo2 in a mutant background, its expression was not enough to rescue
the lateral pathway defect. In this study, we found that a combination of two fragments is enough
to rescue robo2 expression in both midline and the lateral pathway.
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Introduction
The nervous system of vertebrates and non-vertebrates is essential for processing
information and sensing the environment through the basic five senses. Any developmental
defects in the central nervous system (CNS), including proteins involved in axon guidance, can
cause neurological dysfunction such as neurodegeneration, epilepsy, stroke, dementia, traumatic
brain injury, and brain tumors. Despite anatomical differences in the CNS of vertebrates like
humans and invertebrates like Drosophila, they still share several conserved cellular and genetic
properties. For instance, there are around113 different types of neurons have been found in
Drosophila visual system, and a very similar number of these neurons have been identified in
vertebrates (Fischbach & Dittrich, 1989; Dacey & Packer, 2003; Venken et al., 2011). However,
there is a huge number of neurons can be found in vertebrates that are missing in flies. This
reduction in complexity and the feasibility of studying the nervous system in Drosophila helped
the researchers to use Drosophila as a model to obtain novel insight into the tools and
mechanisms that can assist to suggest new treatments for various neurological diseases (Ugur et
al., 2016).
During development, the nervous system relies on axon guidance cues to decide whether
axon fibers cross the midline to the other side of the nervous system or stay on the same side of
the body. These cues can act as attractants or repellents, and axonal growth cones play an
important role in directing these axons to their targets. In Drosophila, a transmembrane protein
family can act as receptors to the repellants. Drosophila has three transmembrane proteins called
roundabout (Robo) proteins (Robo1, Robo2, and Robo3), all of which are responsible for axonal
midline repulsion. However, one of these proteins, Robo2, has three distinct roles. In addition to
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axonal repulsion, Robo2 can mediate pro-crossing the midline and promotes the formation of the
longitudinal pathway (Rajagopalan, Vivancos et al., 2000; Simpson, Bland et al., 2000)
Robo2 is a member of an evolutionarily conserved transmembrane protein family called
roundabout that acts as axon guidance receptors. Robo2 protein consists of two main portions.
The extracellular portion consists of five immunoglobulin-like (Ig) domains and three
fibronectin-like (Fn) domains, while the cytoplasmic portion consists of two short, conserved
motifs (CC0 and CC1) (Figure 2.1). During the early stages of axon trajectory, Robo2 is
expressed in the ipsilateral pioneer axon where it mediates midline repulsion. Robo2 also inhibits
slit Robo1 repulsion by being expressed in the midline cells. Furthermore, Robo2 is expressed in
the lateral regions of the neuropile in the late stages of nerve cord development to enhance the
formation of the longitudinal axon pathways. Robo2 has been studied in the previous years;
however, it is not fully understood how Robo2 can regulate diverse axon guidance outcomes.
The distinct roles of Robo2 depend in part on different functional domains within its receptor
protein, and on its dynamic expression in different subsets of the cells during embryogenesis in
another part.
As our understanding increases about the role of enhancer elements in gene expression,
the notion of gene regulation becomes more sophisticated. Even though these regulatory
elements were described previously, the mechanisms by which these regulatory elements work
still controversial. Genetic variation leads to phenotypic variants and potential diseases. These
variations are located outside of the genes and more likely in the cis-regulatory elements.
Therefore, understanding these mechanisms is significant in this field (Pennacchio et al., 2013).
Transcriptional enhancers are short cis-acting DNA sequences that control gene expression
(Benabdallah & Bickmore, 2016). The human genome contains approximately hundreds of
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thousands of enhancers. Enhancers can function in a position and orientation-independent
manner from their target promoters. Although they regulate genes in cis, enhancers can be in
different positions. They can be found upstream, downstream, or within the introns of a gene.
Some enhancers were found very close to their target promotors, such as SV40, which was the
first discovered enhancer. SV40 enhancer is 72 bp tandem in a sequence that is located ̴100 bp
upstream of the viral core promoter (Benabdallah & Bickmore, 2016). Studies showed that
deletion of SV40 enhancer can eliminate gene expression and loss the viral activity (Benoist &
Chambon, 1981; Gruss et al., 1981). Other enhancers were found far away from their promoter,
such as but not limited to β-globin (LCR), which can be found tens of kilobases from its target
promoter, while Shh limb enhancer (ZRS), developmental enhancer, can be located hundreds or
1000 kb from its target gene (Figure 2.2). This chapter focuses on transcriptional regulation of
Drosophila robo2 to address the question of how individual genes can lead to different axon
guidance outcomes. To examine the location of the regulatory regions of the robo2 gene, I tested
genetic fragments (potential enhancers) in the first intron and upstream of the robo2 gene that
could be potentially involved in the regulation of robo2 expression. Drosophila transgenic lines
called Janelia GAL4 lines were used in this experiment. These lines have been generated by
Janelia Research Campus to investigate the location of enhancers in many neuronal genes
including robo2. Seventeen of these lines have been created by cloning fragments of robo2 and
these fragments are inserted upstream of the yeast transcriptional activator GAL4 (Pfeiffer et al.,
2008). Each one of the seventeen lines was crossed to another transgenic line containing a GAL4
responsive GFP (UAS-TauMycGFP) to create a protein reporter system (Figure 2.3).
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Figure 2.1: Structure and function of Robo2 receptor. Left panel, Robo2 schematic
structure, Robo2 is a transmembrane protein consists of extracellular portion contains five
Ig-like domains and three fibronectin-like domain, and cytoplasmic portion consists of two
short, conserved motifs (CC0, and CC1). Right panel, schematic of the nerve cord of
Drosophila. It shows the three distinct axon guidance decisions controlled by robo2 in
preventing midline crossing by binding to slit (purple), mediating longitudinal pathway
formation in the lateral neuropile (green), and antagonizing slit-Robo1 repulsion and
promoting midline crossing(orange).
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Figure 2.2. Different distances between enhancers and their promoters. (Top) SV40 early
promoter as an example of an enhancer that is located a few tens of bp from their target
promoter. (Middle) β-globin locus control region (LCR) as an example of enhancers that
are found tens of kilobases from their target gene. (Bottom) Shh limb enhancer (ZRS) as
an example of developmental enhancers that are located hundreds or 1000 kb from their
target promoter. This picture is adapted from (Benabdallah & Bickmore, 2016)
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Figure 2.3: Janelia GAL4 lines. A schematic shows crosses between UAS-GFP and
Janelia GAL4 lines containing robo2 fragments. The expression patterns of the GFP is
directed by the presence or absence of the enhancers in each robo2 fragment. The robo2
transcription factors in the CNS bind to the robo2 putative enhancers present in each
fragment upstream of the GAL4. As GAL4 protein produces, it binds to UAS enhancer
and promotes GFP expression. The GFP expression reflects the expression governed by
robo2 transcriptional elements.
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Material and Methods
Molecular biology
Rescue construct synthesis: All Janelia GAL4 fragments were amplified by using specific
primers (Table 4) and fly genomic preparations using Phusion Flash PCR Master Mix (Thermo
Scientific), Both PUAST vector and Janelia fragments were cut by AscI restriction enzyme.
Gibson Assembly synthesis reaction or Gibson assembly Ultra Kit (SGI-DNA, Inc. La Jolla, CA
92037 USA, Cat no.:GA1200-10) were used to fusing Janelia fragments with the P10-UAST
vector backbone to form a rescue construct vector, which is transformed into competent E. coli
cells and recovered through mini preparation (Qiaprep spin miniprep kit (250), Cat. no. 27106).
All the constructs were confirmed by PCR followed by sequencing to ensure that all the
fragments were inserted correctly into P10-UAST vector. Rescue constructs including Janelia
GAL4 fragments and robo2 HA-tagged cDNA were inserted at the attB site located at 28E7
position on the left arm of chromosome 2. The transgenic lines resulted from this cloning
carrying rescue constructs were crossed to Sco/CyOwg flies which are utilized as genetic
balancers.
Immunohistochemistry
Drosophila embryos were collected, dechorionated, and fixed as previously described in
(N. H. Patel, 1994) and stored in methanol at -20°C. Fixed embryos were rehydrated in PBT (
1XPBS, and 0.1% triton) and blocked in PBT+ 5% NGS for 30 minutes at room temperature.
Primary antibody was added and incubated at 4 °C overnight, then washed and incubated with
PBT for 30 minutes at room temperature. Secondary antibody was added and incubated for 1
hour at room temperature and washed 3 times with PBT (1XPBS, and 0.1% triton) and then
rinsed with PBS 10% and mounted in 70% glycerol/PBS. Drosophila embryos were genotyped
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by using balancer markers or using epitope-tagged transgenes. Embryos were dissected to get the
nerve cords of desired genotypes in different stages. Nerve cords were mounted in 70%
glycerol/PBS. Leica SP5 confocal microscope was used for imaging and Fiji/Image J and
photoshop software (Schindelin et al., 2009) were used to process the fluorescent confocal
stacks.
Combining GMR28F02 and GMR28G05 fragments and Generation of CRISPR-modified
alleles recovery
GMR28F02 and GMR28G05 fragments were amplified from genomic DNA preparation
using specific primers (Table 4) and amplified fragments were extracted from the gel and
purified using (QIAquick Gel Extraction Kit (250) Cat. No. 28706). Gibson assembly master mix
used to assemble these fragments in P10-UAST vector backbone that has HA-tag to form a
rescue construct plasmid. The assembled vector was transformed into competent E. coli cells and
recovered through minipreparation (QIAprep Spin Miniprep Kit (250), Cat. No. 27106). The
construct was confirmed by PCR and sequencing. This rescue construct was inserted at attB site
located at 28E07 on the left arm of chromosome 2 of wild-type fly. The G0 flies from this
cloning were crossed to Sco/CyOwg to make balanced stocks. Flies from this combination were
crossed to robo2 null mutant flies. The G0 flies from this cross were individually crossed as
adults to Sco/CyOwg. F1 males were then crossed individually to Sco/CyOwg virgin females.
After 3 days, F1 males were removed from crosses and tested by PCR with primers to confirm
any changes in the robo2 locus. F2 progeny from positive F1 crosses were used to generate
balanced stocks.
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Results
robo2 fragments as putative enhancers reported by GFP expression
Embryos resulted from crossing the 17 lines of robo2 Janelia GAL4 lines to the UASGFP lines were stained by anti-GFP antibody to label GFP product translated under the control
of the robo2 putative enhancers. All the 17 lines were screened by scoring the lines according to
the expression pattern of the GFP in and outside of the CNS, in the Ventral Nerve Cord (VNC),
and the expression in multiple cell-types of interest that normally express Robo2: commissural
axons, midline cells, and longitudinal axons (Figure 2.4). Preliminary results show that six of the
seventeen lines were identified to drive the GFP expression in different axons of VNC. Two of
these 6 fragments drove the expression of GFP in the lateral axons of VNC (GMR28F02 and
GMR28G05). Therefore, GMR28F02 and GMR28G05 were selected as putative enhancers
driving Robo2’s lateral pathway. Two other fragments drove the GFP expression in the midline
glial cells (GMR28E07 and GMR28B05). So, they were selected as putative enhancers driving
robo2 pro-crossing role and considered fragments that have a potential role in midline repulsion
(Figure 2.5). Worth mentioned that two other fragments GMR28C04, GMR28D10 were noted to
drive GFP expression; However, the expression pattern was hard to define accurately (Figure
2.5).
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Figure 2.4. Top, robo2 gene and 17 fragments that represent putative enhancers for the robo2 generated by Janelia Research
Campus, in addition to 3 fragments generated in out lab (SEG01, SEG02, and SEG03). Bottom, Reflective patterns of robo2
expression resulted by crossing Janelia GAL4 lines to UAS-GFP line. A series of transgenic fly strains were generated by
Janelia Research Campus in which the DNA sequences of the robo2 gene were cloned upstream of GAL4 transcriptional
activator. Anti GFP antibody was used to detect the GFP expression to be used as a readout to determine which fragment
indicate each aspect of robo2 expression.

GMR28G05

GMR28B05

Figure 2.5.GFP expression. (Up) GMR28F02 and GMR28G05 lines.
Embryos were stained with anti-HRP and anti-GFP, GFP is expressed in the
longitudinal axons (arrows). (Down) GMR28E07 and GMR28B05 lines.
Embryos were stained with anti-GFP and anti-HRP. GFP is expressed in the
midline glia (arrows).
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Generating and characterizing Robo2 rescue transgenes expressing an HA-tagged robo2
cDNA under the control of candidate enhancer regions
From the above initial screening of a collection of non-coding DNA fragments in the first
intron of robo2 suggested that six fragments (GMR28F02, GMR28G05, GMR28E07,
GMR28B05 GMR28C04, and GMR28D10) have the potential to serve as enhancers for robo2
and four fragments (GMR28F02, GMR28G05, GMR28E07, and GMR28B05) among these six
fragments were stronger putative enhancers. To closely characterize the robo2 expression, all the
above six fragments were introduced into the HA-Robo2 reporter transgene (Figure 2.6),
(Appendix 5). The transgenic robo2 expression was examined by using an anti-HA antibody.
The results suggested that four of these fragments: GMR28F02, GMR28G05, GMR28C04, and
GMR28D10 drove the robo2 expression in different subsets of the longitudinal pathway in stage
16-17 of embryogenesis (Figure 2.7). On the other hand, two fragments (GMR28E07 and
GMR28B05) did not show the robo2 expression in the longitudinal pathway at stages 16-17
while they drove the expression of robo2 in midline glia at stage 13 of embryogenesis (Figure
2.8).
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Figure 2.6. A schematic of the robo2 rescue construct showing the HA-Robo2 cDNA and
the inserting site for Janelia GAL4 fragments (GMR28F02, GMR28G05, GMR28C04,
GMR28D10, GMR28B05, and GMR28E07).
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Figure 2.7: A-D. (GMR28F02)::robo2, (GMR28G05)::robo2, (GMR28C04)::robo2, and
(GMR20D10)::robo2 transgenic lines showing robo2 expression in the longitudinal
pathway in stage 16 embryos stained with anti-HA antibody (green), and anti-HRP
antibody (magenta). Lower images show anti-HA antibody only (arrows) of the same
embryos.
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Figure 2.8.A and B. Embryos stage 13 of (GMR28E07)::robo2 and
(GMR28B05)::robo2 expression showing midline glial cells stained by anti-HA
antibody(green) (A and B, arrowheads) and some of the longitudinal axons (A, arrow).
Anti-HRP antibody (magenta) stained Drosophila nerve cord. Lower images (C and D)
show stage 16 embryos of (GMR28E07)::robo2 and (GMR28B05)::robo2, no expression
of robo2 in the lateral pathway. Right images of A-D represent HA channel alone.
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Characterize additional potential regulatory regions not included in the original Janelia
GAL4
In addition to the DNA fragments holding suggested putative regulatory regions in the
first intron of the robo2 gene, there are potential enhancers situated upstream of the robo2 DNA
sequence, these regions are not part of the Janelia GAL4 lines. To cover these promoter-proximal
regions, three additional DNA fragments (SEG01, SEG02, and SEG03) located ̴ 20 kb upstream
of the robo2 promoter were cloned by introducing them separately into HA–Robo2 reporter
transgene(Figure 2.9) (Appendix 5). The expression of these transgenes was characterized as
described in figures 2.10 and 2.11. SEG01 does not show any robo2 expression in the lateral
pathway at stage16. However, it shows a slight expression at midline glia at stage 13 of
embryogenesis. SEG02 and SEG03 on the other hand show robo2 expression in different subsets
of the lateral longitudinal neurons at stage 16 of the embryogenesis (Figure 2.11, A and B).
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Figure 2.9. A schematic of the robo2 rescue construct showing the HA-Robo2 cDNA
and the inserting site for non-Janelia GAL4 fragments that are located upstream of the
robo2 DNA sequence (SEG01, SEG02, and SEG03)
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Figure 2.10. (SEG01)::robo2. A. Stage 16 embryo stained with anti-HRP
antibody(magenta), and anti-HA antibody(green) showing no expression of robo2
in the lateral pathway at this stage of embryogenesis. B. Stage 13 shows a little
(arrow) or no expression for the robo2 at this stage in the midline glia. Lower
images show HA staining channel only for the both stages.
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Figure.2.11. robo2 expression patterns driven by SEG02 and SEG03. A.
(SEG02)::robo2 shows robo2 expression in a subset of the longitudinal pathway
(A, arrow) and some neurons outside of the nerve cord (A, arrowhead) stained
with anti-HA antibody. The nerve cord is stained with anti-HRP
antibody(magenta), B. (SEG03)::robo2 shows robo2 expression in a subset of
the lateral pathway (B, arrow) using anti-HA antibody(green), and anti-HRPantibody(magenta) to stain Robo2 and the nerve cord, respectively. Lower
images represent HA staining channel only.
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Compare exogenous HA-Robo2 expression with the full robo2 expression (endogenous) and
compare that with the Janelia GAL4 lines for each enhancer region
To investigate whether the putative enhancers would drive robo2 expression as strong as
the native enhancer (not well understood yet), GMR28F02 and GMR28G05 fragments, gave
strong expression in subsets of the robo2’s longitudinal pathway, were chosen for this
comparison. Since we do not have a good Robo2 antibody, and even if we had one, it would not
work with this experiment since the rescue transgene is also expressing Robo2. To overcome
such obstacles, the CRISPR-Cas9 gene-editing tool has been used to generate a line where
Robo2 was labeled with Myc tag. Flies that have Myc-Robo2 were crossed to the ones that have
GMR28F02::HA-Robo2 and GMR28G05::HA-Robo2 separately (Appendix 4.4). Embryos were
collected from the progeny of this cross were stained with anti-HA and anti-Myc antibodies. The
results showed that some neurons are labeled with HA and Myc antibodies which indicated that
both HA-Robo2 and Myc- Robo2 were expressed. Noticeably, HA-Robo2 and Myc- robo2
expressions were found in subsets and the entire lateral pathways, respectively (Figure 2.12). To
further investigate whether these two fragments (GMR28F02 and GMR28G05) can rescue the
robo2 full expression in the lateral pathway, a recombinant line was made by crossing
GMR28G05 and GMR28F02 transgenes separately to a CRISPR allele robo2 myc- robo2 line and
their progeny {((GMR28G05):: robo2/ robo2 myc- robo2 , and (GMR28F02):: robo2/ robo2 mycrobo2

)} were crossed with each other. To make sure that both HA- and Myc- Robo2 were existed

in the same fly, PCR reactions with specific primers were conducted. Positive embryos were
collected and stained with anti-HA and anti-Myc. The results showed that HA still labels some of
the Myc axons but not all of them. These findings suggested that the presence of one copy of
each fragment on each allele is not enough to fully rescue the robo2 expression (Figure 2.12, C).
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Figure 2.12. Compare the endogenous robo2 expression with the exogenous HA-tagged
robo2. A. Stage 16 embryo of (GMR28G05):: robo2 / robo2 Myc-Robo2 shows anti-Myc
antibody labeling all the neurons that normally express robo2, and anti-HA antibody
represents the exogenous robo2 driven by GMR28G05 fragment, labeling a subset of Myc
(A, arrow show the region where both Myc and HA are labeled in the same embryo. ( A,
arrowhead shows only Myc axons) B. Stage 16 embryo of (GMR28F02):: robo2 / robo2
Myc-Robo2
shows anti-Myc antibody labeling the neurons that normally express endogenous
Robo2, and anti-HA antibody labeling the exogenous Robo2 driven by GMR28F02
fragment showing a subset of Myc labeled (B, arrows). C. Stage 16 embryo of genotype [
[(GMR28G05):: robo2], [ robo2 Myc-Robo2]/ [ (GMR28F02):: robo2], [ robo2 Myc-Robo2]
shows the endogenous and exogenous robo2 expression resulted by a single copy of each
of GMR28G05 and GMR28F02 fragments. Lower images show HA channel only.
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Then we asked whether the robo2 expression driven by the rescue constructs have identical or
different patterns than the ones which led by the original Janelia GAL4 lines. The analysis of 17
transgenic lines generated by Janelia GAL4, where GAL4 was expressed under the control of the
robo2 DNA fragments sequence revealed that some of these fragments drove the expression in
the longitudinal pathway and some of them showed the expression in the midline glial cells.
(GMR28F02):: robo2, (GMR28G05):: robo2, (GMR28C04):: robo2, and (GMR28D10):: robo2
of the rescue construct showed distinct expression patterns in different subsets of the longitudinal
pathway at stage 16 of the embryogenesis and this is consistent with what Janelia GAL4 lines
showed (Figure 2.13). On the other hand, while Janelia GAL4 lines GMR28E07 and GMR28B05
showed expression in the midline glia at the stage16 of the embryogenesis, rescue constructs
transgenes of the same fragments did not show the same expression at that stage. However, stage
13 embryos of these fragments showed the same expression in the midline glia in the rescue
constructs transgenes.
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Figure 2.13.
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Figure 2.13. (Cont.) Comparison of robo2 expression driven by the DNA fragments
in the original Janelia GAL4 and the rescue construct transgens.1-4. robo2 expression
driven by GMR28F02, GMR28G05, GMR28C04, and GMR28D10 fragments
respectively in the Janelia GAL4 (A) and rescue construct (B). The lateral pathway is
stained with anti-GFP antibody in A and anti- HA-antibody in B, and the nerve cord is
stained with anti-HRP (blue in A) and (purple in B). Lower images represent the GFP
and HA channels only.
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Figure 2.14
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Figure 2.14. (Cont.) Compare robo2 expression driven by GMR28E07 fragment in the
original Janelia GAL4 and the rescue construct transgenes. A. Stage 16 embryo
represents robo2 expression driven by GMR28E07 fragment in the midline glia of
Janelia GAL4 line stained with anti-GFP (green) and the nerve cord is stained with antiHRP (blue). (B) Stage 16 embryo shows very little or no expression of robo2 driven by
GMR28E07 fragment of the rescue construct transgene in this stage of embryogenesis.
C. Stage 13 embryo represents robo2 expression driven by GMR28E07 fragment in the
midline glia of rescue construct transgene stained with anti-HA antibody(arrowhead)
and a subset of the longitudinal pathway (arrow). The nerve cord is stained with antiHRP (purple). Right image in A represents the GFP channel only and the right images
in B and C represent HA channel alone.
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Figure 2.15
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Figure 2.15. (Cont.) Comparison of robo2 expression driven by GMR28B05 fragment
in the original Janelia GAL4 and the rescue construct transgenes. A. Stage 16 embryo
represents robo2 expression driven by GMR28B05 fragment in the midline glia of
Janelia GAL4 line stained with anti-GFP (green, arrowhead) and the nerve cord is
stained with anti-HRP (blue). (B) Stage 16 embryo shows very little or no expression of
robo2 driven by GMR28B05 fragment in the rescue construct transgene in this stage of
embryogenesis. C. Stage 13 embryo represents robo2 expression driven by GMR28B05
fragment in the midline glia of rescue construct transgene stained with anti-HA antibody
(green, arrowhead) and the nerve cord is stained with anti-HRP (purple). Right image in
A represents the GFP channel only and the right images in B and C represent HA
channel alone.
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Combinatorial enhancers and robo2 full expression
GMR28G05 and GMR28F02 transgenic lines show strong expression of the robo2 in
subsets of the longitudinal lateral axons. The previous experiment described early in this chapter
shows involving one copy of each fragment on each allele is not enough to drive the full
expression of the robo2 in the longitudinal pathway. Therefore, we asked whether combining the
two fragments (GMR28G05 and GMR28F02) as one big fragment would recover the full
expression of the robo2. Gibson assembly approach was used to combine GMR28G05 and
GMR28F02 fragments and introduce them to the HA-Robo2 reporter transgene. This reporter
was introduced to Drosophila to generate a new transgenic line. Homozygous embryos of the
progeny of this line were collected and stained with anti-HRP and anti HA antibodies. The
results revealed that the number of cell bodies is doubled when the two fragments (GMR28G05
and GMR28F02) were combined and integrated on the same chromosome in tandem compared
to the few cell bodies that were labeled in the (GMR28G05):: robo2 and (GMR28F02):: robo2
separately (Figure 2.16, C, arrowheads). However, the expression of the robo2 in the
longitudinal pathway was not fully recovered (Figure 2.16, C, arrows).
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Figure 2.16. Combinatorial expression of robo2 enhancers (GMR28G05+GMR28F02). A
and B show robo2 expression which was led by GMR28G05 and GMR28F02 separately.
Anti-HRP antibody labels Drosophila nerve cord and anti-HA antibody labels subsets of
the robo2 in the longitudinal pathway (arrows) and some few neurons around the nerve
cord (arrowheads). C. shows the tandem of (GMR28G05+GMR28F02) fragments on the
same chromosome of the same embryo. Although the number of the labeled neurons with
anti HA- antibody was increased, the longitudinal pathway still shows the robo2
expression in subset of the lateral axons. Lower images show the HA channel alone.
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The rescue of axon guidance decision of robo2 mutant background
This study shows that some of the DNA sequences surrounding the robo2 promoter are
potential enhancers that can regulate robo2 expression in specific patterns. We hypothesized that
these DNA regions that drove the expression of the robo2 in the longitudinal pathway should be
able to rescue the lateral pathway defects in the robo2 mutant background. The same hypothesis
can be applied to ensure that the fragments driving robo2 expression in the ipsilateral neurons
can rescue the midline ectopic crossing defects caused by the loss of the Robo2. To test this
hypothesis, the HA-Robo2 transgenes (GMR28G05):: robo2 and (GMR28F02)::rboo2 were
introduced to robo2 null mutant background (Appendix 4), where small deletions occurred in
the robo2 coding region due to imprecise excision of a p-element transposon upstream of the
robo2 signal sequence. These deletions were designed to behave like genetic null alleles
(Simpson, Bland et al., 2000). Midline ectopic crossing and the lateral pathway defects were
quantified comparing to the wild-type and robo2 mutant embryos. Data show that GMR28F02
enhancer does not rescue the robo2 expression neither in the midline ectopic crossing nor in the
longitudinal pathway. In other words, the expression driven by GMR28F02 was not sufficient to
recover the defect that occurred in the midline glia and the lateral pathway in stage 16 in robo2
mutant embryos. Statistical analysis shows the differences between the robo2 mutant carries the
robo2 (GMR28F02):: robo2 transgene and robo2 mutant in both rescuing the midline ectopic
crossing and the lateral pathway were not statistically significant (p= 0.2223) and (p=0.075),
respectively (Figure 2.17, C, and bottom bar graphs). robo2123/robo2135 embryos showed 22.1%
instances of the lateral pathway formation defects, while robo2123, [GMR28F02-robo2]/robo2135,
[GMR28F02-robo2] embryos, which are expected to show rescue of Robo2’s lateral positioning
role, showed 18.6% instances of the lateral pathway defects indicating that the instances of the
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lateral positioning defects in robo2123, [GMR28F02-robo2]/robo2135, [GMR28F02-robo2] showed
a non-significant statistical difference from the 22.1% defects of hetero-allelic robo2 mutants, in
other words, the presence of the GMR28F02- robo2 transgenic modification was not sufficient to
rescue Robo2’s lateral positioning role. (Table 2.1). Also, robo2123/robo2135 embryos showed
17.1% instances of midline ectopic crossing, and the instances of midline crossing rescue in
robo2123, [GMR28F02-robo2]/robo2135, [GMR28F02-robo2] showed 22.9% which was
statistically not different from the 17.1% defects of hetero-allelic robo2 mutants, indicating that
the presence of the GMR28F02- robo2 transgenic modification was not sufficient to rescue
Robo2’s midline ectopic crossing role occurred by hetero-allelic robo2 mutants.
GMR28G05 on the other hand showed a rescuing for the midline ectopic crossing
(P=0.0004). However, its expression was not enough to rescue the lateral pathway defects since
there were no significant differences in the lateral longitudinal pathway between robo2 transgene
carrying GMR28G05 (robo2 (GMR28G05):: robo2) and robo2 mutant background (p=0.0813)
(Figure 2.18, C, and bottom bar graphs). Homozygous-allelic robo2 mutants of genotype
robo2135/robo2135 showed instances of the midline ectopic crossing of 40.06% while robo2135,
[GMR28G05-robo2]/robo2135, [GMR28G05-robo2] showed instances of 7.14% in the midline
ectopic crossing, indicating that the instances of ectopic midline crossing in robo2135,
[GMR28G05-robo2]/robo2135, [GMR28G05-robo2] showed a significant statistical difference
from the 40.06% defects of homo-allelic robo2 mutants (Table 2.2). Instances of the lateral
pathway defect in Homozygous-allelic robo2 mutants were 20.7%while robo2135, [GMR28G05robo2]/robo2135, [GMR28G05-robo2] showed 6.42% instances in the lateral pathway, which was
not significantly different from the 20.7% of homo-allelic robo2 mutants (Table 2.2).
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In addition to the single fragment rescue experiment, I performed crosses between the
line carrying the combination of GMR28G05 and GMR28F02 ((GMR28G05+GMR28F02)::
robo2) and robo2 mutant background line to obtain embryos of homozygous-allelic genotype for
the robo2 mutations robo2135, [GMR28G05+GMR28F02-robo2]/ robo2135,
[GMR28G05+GMR28F02-robo2]. These embryos were stained, imaged, and scored for defects
in the formation of the lateral axon pathways and ectopic axons crossing the midline (Figure
2.18, D). Homozygous-allelic robo2 mutants of genotype robo2135/robo2135 were also scored in
the same way. robo2135/robo2135 embryos showed 20.7% instances of the lateral pathway
formation defects, while robo2135, [GMR28G05+GMR28F02-robo2]/robo2135,
[GMR28G05+GMR28F02-robo2] embryos, which are expected to show rescue of Robo2’s
lateral positioning role, showed 4.45% instances of the lateral pathway defects indicating that the
instances of the lateral positioning defects in robo2135, [GMR28G05+GMR28F02robo2]/robo2135, [GMR28G05+GMR28F02-robo2] showed a significant statistical difference
from the 20.7% defects of homozygous-allelic robo2 mutants, demonstrating that the presence of
the combinatorial transgenic modification was sufficient to rescue Robo2’s lateral positioning
role (Table 2.2). Also, robo2135/robo2135 embryos showed 40.06% instances of midline ectopic
crossing, and the instances of midline crossing rescue in robo2135, [GMR28G05+GMR28F02robo2]/robo2135, [GMR28G05+GMR28F02- robo2] showed 10.72% which was statistically
different from the 40.06% defects of homozygous-allelic robo2 mutants, indicating that the
presence of the combinatorial transgenic modification was sufficient to rescue Robo2’s midline
ectopic crossing role occurred by the homozygous-allelic robo2 mutants.
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Figure 2.17. (Cont.) robo2 rescue using single fragment (GMR28F02). (A-C) Stage 16
embryos stained with anti-HRP (magenta) and anti-FasII (green) antibodies. Lower
images show FasII channel alone for the same embryos. FasII-positive axons in robo2
null mutants cross the midline inappropriately in some segments (B, arrow), and show
defects in the lateral pathway (B, arrow with asterisk). This phenotype is not rescued by
the robo2 (GMR28F02):: robo2 transgene having GMR28F02 fragment that drives robo2
expression in the lateral pathway (C, arrow with asterisk ) and midline (C, arrow). Bar
graphs in the bottom indicate instances of ectopic midline crossing (left) and the lateral
pathway defects(right)(A-C). Error bars indicate standard error.
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Figure 2.18. (Cont.) robo2 rescue using GMR28G05 and combinatorial (tandem) of
GMR28G05+GMR28F02 putative enhancer regions. (A-C) Stage 16 embryos stained
with anti-HRP (magenta) and anti-FasII (green) antibodies to label the nerve cord and
axon pathways, respectively. Lower images show FasII channel alone for the same
embryos. Medial FasII axons cross the midline ectopically in homozygous robo2 null
mutants (B, arrow), and the lateral axon pathways do not form appropriately (B, arrow
with asterisk). This phenotype is rescued in the midline by the robo2(GMR28G05)::robo2
transgene having GMR28G05 fragment (C, asterisk). However, this fragment did not
rescue the lateral defect occurred by robo2 null mutant (C, arrow, and asterisk). On the
other hand, combinatorial of two fragments GMR28G05+GMR28F02 shows fully rescue
of robo2 expression in the midline and the lateral pathway(D). Bar graph on the left
bottom indicates instances of restoring ectopic midline crossing in
robo2(GMR28G05)::robo2 and robo2(GMR28G05+GMR28F02)::robo2 and on the right
bottom indicates instances of rescuing the lateral pathway defects in the
robo2(GMR28G05)::robo2 and robo2(GMR28G05+GMR28F02)::robo2. Error bars
indicate standard error.
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Table 2.1
Genotype

Population size,
n

% Ectopic

% Lateral Pathway

Crossing

Defects

robo2

10

17.1

22.1

robo2,
robo2(GMR28F02):: robo2

10

22.9

18.6

Table 2.2
Genotype

Population size,
n

% Ectopic

% Lateral Pathway

Crossing

Defects

robo2

10

40.06

20.7

robo2,
robo2(GMR28G05):: robo2

10

7.14

6.42

robo2,
robo2(GMR28G05+GMR28F02)::
robo2

8

10.72

4.45
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Generate and characterize an equivalent set of robo2 transgenes expressing the axonal
marker TauMyc instead of the HA-Robo2
Robo2 is expressed normally in a subset of longitudinal axons. To unravel the robo2
candidate enhancers underlying the expression in these axons without relying on robo2
expression, I generated an equivalent set of the robo2 transgenes that express the axonal marker
TauMyc. This transgene consists of Drosophila robo2 promoter followed by TauMyc cDNA.
The embryos of this transgene were collected and stained by anti-HRP and anti-Myc antibodies.
However, the expression was too weak to be studied (Figure 2.20, A). robo2 promoter was
replaced by hsp70 promoter since the first one did not show a good expression. The GMR28F02
fragment was cloned into the TauMyc construct (Figure 2.19), and TauMyc expression was
examined in embryos carrying this transgene. Results show that GMR28F02 fragment in
hsp70(GMR28F02)::TauMyc drove strong TauMyc expression in a subset of the lateral neurons,
it also labeled the cell bodies and axons including commissural axon segments from which
Robo2 protein is expressed (Figure 2.20, B).
The previous studies show that robo2 misexpression prevents longitudinal axons to form
correctly (Simpson, Bland et al., 2000). Robo2 in recent experiments has shown responsibility
for regulating axon guidance in both ways, cell-autonomously and cell non-autonomously. In
robo2 mutants, FASII positive lateral axons fail to form appropriately. It is unknown whether
these FASII axons express Robo2, so they show defects in their expression when robo2 is
missing. Or axons that express Robo2 normally show the same defects that FASII axons show,
and whether these axons always colocalize with FASII positive axons. We utilized the generated
transgenic line that expresses TauMyc in a subset of longitudinal axons that express robo2
normally (hsp70(GMR28F02)::TauMyc) to test that. This transgene is introduced into robo2 null
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mutant background and TauMyc axon positions were quantified by measuring their distances
from the midline in five hemi segments of each embryo in both wild-type and robo2 null mutant.
FASII axons positions were also quantified in the same way. Results show that TauMyc label
axons express a significant guidance defects in robo2 mutants (****p<0.0001). These axons
show shifting to positions closer to the midline. The average distance of these axons from the
midline is 9.66 µm in the robo2 mutants while it is 13.11 µm in the wild-type. While the HRP
axons are 15.23 µm in distance from the midline and TauMyc axons usually make a position of
13.11 µm in the wild-type, the mutants with the whole scaffold are down to 9.04 µm for the HRP
and the TauMyc axons right now are 9.66 µm. FASII axons show multiple breaks and shifting
from and between zones. They show a significant defect in robo2 mutant (****p<0.0001). FASII
average distance from the midline is 11.97 µm in the wild-type. However, their distance from the
midline in robo2 mutant is down to 7.41 µm.
I have generated another transgenic line that expresses the axonal marker TauMyc in a
subset of longitudinal neurons that express Robo2 normally by using GMR28G05
(hsp70(GMR28G05TauMyc). Embryos from this transgenic line were collected, stained with
anti-HRP, anti-FASII, and anti-Myc antibodies. Interestingly, TauMyc axons that express Robo2
normally in the longitudinal neurons were missing (Figure 2.20, D).
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Figure 2.19. A schematic of TauMyc construct showing TauMyc cDNA with hsp70 promoter
and the inserting site for GMR28F02 fragment.
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Figure 2.20

65

Figure 2.20. (Cont.) Non-autonomous role of Robo2 in the formation of the lateral
pathway. A. GMR28F02::TauMyc embryos at stage 16 shows TauMyc, an axon marker
expresses Robo2 normally in the lateral pathway stained with anti-HRP (blue), anti-FASII
(red), and anti-Myc (green). B. hsp70(GMR28F02)::TauMyc embryo where Robo2
promoter was replaced by HSP70 to show TauMyc axons clearly. C.
hsp70(GMR28F02)::TauMyc in robo2 mutant background (Robo2135) showing the lateral
FASII pathways do not form correctly (lower channel, arrows), and they do not colocalize
with TauMyc axons (arrows in C, and second lower channel of C, and third lower channel
of C). TauMyc axons do not show the same defects that FASII show in robo2 mutant
background (hsp70(GMR28F02)::TauMyc /Robo2135. D. hsp70(GMR28G05)::TauMyc
where Robo2 promoter was replaced by HSP70 second lower channels show isolated
FASII channels from the same embryos. Third layer images show isolated TauMyc
channels from the same embryos. Bottom channels show separated HRP channel from the
same embryos.

66

1 0

5

m id lin e

F A S II

1 5

****

a n d

m ic r o m e te r b e tw e e n

1 5

in

m ic r o m e te r
b y

****

D is ta n c e

in te n s ity

m e a s u r e d

o f H R P s c a fo ld

2 0

F A S II la te r a l a x o n s

H R P

1 0

5

0

0
T

T
W

T

T

M

M

W

m id lin e

1 0

a n d
a x o n s

in
D is ta n c e

****

1 5

T a u M y c

m ic r o m e te r b e tw e e n

T a u M y c

5

0
T

T
M

W

Figure 2.21. Bar Graphs showing the defect that FASII and TauMyc axons display in
hsp70(GMR28F02)::TauMyc in robo2 mutant background. The distance between FASII
and TauMyc axons and midline was measured for five locations per embryo. Each variant
was compared in +, hsp70(GMR28F02)::TauMyc embryos and mutants by a Student’stest. We detect a statistically significant decrease in a distance from the FASII and
TauMyc axons to the midline in embryos expressing hsp70(GMR28F02)::TauMyc in
robo2 mutant background (robo2135) compared to wild type embryos expressing
(hsp70(GMR28F02)::TauMyc (p<0.0001).
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Discussion
Robo2 is a member of conserved protein family that responds to Slit ligand and plays a
role in several aspects of axon guidance (Evans et al., 2015). The question remains as to the
ways by which Robo2 acts in making such different functions. robo2 expression has previously
been shown to be transient through embryonic developmental stages (Rajagopalan, Vivancos et
al., 2000). While Robo2 is broadly expressed in the CNS during the early stages of development,
its expression becomes more limited to axons in the lateral one-third of the longitudinal pathway
in later stages. This project hypothesizes that different regulatory regions surrounding the robo2
gene direct robo2 expression in a specific special and temporal pattern during embryonic
development, and this expression is orchestrated by gene control mechanisms through regulating
regions that control robo2 expression in specific cell types or specific developmental stages.
With one or multiple enhancers controlling one aspect of robo2’s expression. The research in
this chapter focuses on the robo2 fragments role in driving a specific robo2 expression in the
lateral pathway and midline glial cells. The fragments tested in this chapter have been confirmed
to be able to drive a specific robo2 expression in the lateral axons and glial cells indicating that
these putative enhancers exist on these fragments. For instance, GMR28F02, GMR28G05,
GMR28C04, and GMR28D10 drove robo2 expression in the lateral pathway. Two more
overlapping fragments (SEG02 and SEG03) generated in our lab (not included in the original
Janelia GAL4) that are located upstream of the robo2 gene have shown expression in the lateral
pathway as well. Moreover, two other fragments (GMR28E07 and GMR28B05) showed
expression in the midline glia. Even though there is no overlapping between GMR28E07 and
GMR28B05 fragments, the expression patterns that they show is identical in both Janelia GAL4
lines and the rescue construct transgenes at almost all stages. They both show an expression in

68

the midline glial cells. However, these two fragments are separated from each other by
GMR28A10 fragment. Interestingly this fragment (GMR28A10) does not show any expression
in Janelia GAL4 lines even if a part of GMR 28A10 sequence overlaps with GMR28B05. Figure
2.4. I suggest that using CRISPR cas-9 based gene-editing to delete the region shared between
GMR28A10 and GMR28B05 from GMR28B05 fragment and then combine the remaining
fragment of GMR28B05 with GMR28E07 fragment would be sufficient to drive robo2 full
expression in the midline glia.
Putting the rescue constructs in the robo2 mutant background drove the expression of
robo2 in subsets of the lateral pathway and midline to play a role in these two positions.
However, these constructs represented by (GMR28G05):: robo2, and (GMR28F02):: robo2,
separately failed to rescue the whole function of Robo2 in the lateral pathway formation.
Interestingly, (GMR28G05):: robo2 construct that expected to rescue robo2 expression in the
longitudinal pathway displayed restoring of the essential Robo2 function to prevent midline
ectopic crossing. To explain that, we need to look closer to the original Janelia GAL4 lines,
GMR28G05-GFP line shows some of the cells are expressed in the midline, which makes it
possible for (GMR28G05):: robo2 to rescue the ectopic midline crossing. The question still
arises as why transgenic constructs that led the expression in specific cell subsets were not able
to completely rescue the robo2 expression in that position? If we go back to the initial screening
of Janelia GAL4 lines we can notice that multiple lines besides tested ones showed GFP
expression in the lateral pathway and midline glia. In other words, not only the tested lines
expressed Robo2 in different cell types and different stages, but also some other lines showed
GFP expression, but that expression was hard to define accurately, which suggests that multiple
fragments may be required to regulate a single aspect of robo2 expression. Also, some of Janelia
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GAL4 lines such as GMR28E07-GFP and GMR28B05-GFP that showed expression at stage 16,
the same expression was missing in the rescue transgenes at the same stage. One possible
explanation for that is because of the difference in the expression duration between Janelia
GAL4 lines and the rescue construct transgenes. The GFP expression pattern can be seen in both
early and late stages of Janelia GAL4 lines while the expression pattern was restricted to earlier
stages of the embryogenesis in the rescue transgenes. Robo2 cytosolic mRNA appears for a short
time before being translated to a protein. However, GFP lasts longer than the mRNA and that is
why it shows the robo2 expression at later 16 stages while the actual expression was in the stage
13 of the embryogenesis.
The rescue of the axon guidance decision of robo2 mutant background by the
combinatorial of robo2 enhancers
Since single fragment transgenes did not show a full rescue for the longitudinal pathway
of robo2 expression, I hypothesized that combinatorial of two fragments that have expression
patterns in the longitudinal pathway would rescue the robo2 expression in the lateral pathway.
GMR28G05 and GMR28F02 fragments were combined in tandem in one construct and injected
into wild-type fly by Best gene, then a fly stock balancer made and crossed to the mutant
background. homozygous-allelic genotype embryos with respect to the Robo2 mutations
robo2135, [GMR28G05+GMR28F02-robo2]/ robo2135, [GMR28G05+GMR28F02-robo2] were
collected, stained, imaged, and scored for defects in the formation of the lateral axon pathways
and for ectopic axon crossing of the midline. Homozygous-allelic robo2 mutants of genotype
robo2135/robo2135 were also scored in the same way. The homozygous-allelic genotype robo2135,
[GMR28G05+GMR28F02-robo2]/ robo2135, [GMR28G05+GMR28F02-robo2] was able to
rescue the robo2 expression not only in the lateral pathway formation but also in the midline
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repulsion. The instances of the lateral positioning defects in robo2135, [GMR28G05+GMR28F02robo2]/robo2135, [GMR28G05+GMR28F02-robo2] showed significant statistical difference from
the defects of homozygous-allelic robo2 mutants in both lateral and midline ectopic crossing.
Together, these results confirm that multiple enhancer regions are required to restore the full
robo2 expression.
TauMyc marker transgene confirm cell non-autonomous role of Robo2
Robo2 receptor regulates the lateral positions of the axons in the VNC of Drosophila
CNS by responding to Slit ligand. Drosophila wild-type embryos show three FASII positive on
both sides of the midline. The previous studies show removal of robo2 causes fusing the lateral
FASII pathway with the intermediate pathway and directs the lateral axons medially (Ströhl et
al., 2017). Another study shows that robo2 misexpression prevents the formation of the
longitudinal pathway appropriately (Simpson, Bland et al., 2000). Moreover, ectopic expression
of robo2 lead the medial axons to be extended laterally. (Simpson, Bland et al., 2000; Spitzweck
et al., 2010) show that replacing robo2 by robo1 causes the lateral pathway fails to form
correctly. However, HA-positive axons that express Robo1 instead of Robo2 still able to be
expressed laterally. We need to know if axons expressing Robo2 normally show any defects in
robo2 mutant background and whether this defect looks like the one that FASII axons show. We
also want to know the autonomy express of Robo2 by normally expressing axons. The previous
studies showed that Robo2 can act cell-autonomously and non-autonomously to regulate the
lateral axons. We show here that TauMyc axons that normally express Robo2 in the lateral axons
act as cell non-autonomously in robo2 mutant. However, the defects they show is different than
the one that FASII show. The question remains as to whether TauMyc axons colocalize with
FASII axons. The answer is no. Although they both show significant defects by being shifted
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from the midline in robo2 mutants, they still do not show the same defects and navigation in
their expression. Together, these data show that FASII and TauMyc axons are not the same.
Not only GMR28F02 was cloned in the TauMyc construct, but also GMR28G05 was
cloned in the same construct. Unlike hsp70(GMR28F02)::TauMyc, hsp70(GMR28G05):
:TauMyc did not show any expression. We do not know if this missing of expression has been
occurred due to the replacing of the endogenous promoter by hsp70 or it happened in the original
transgene when we replaced the robo2 construct by TauMyc. To answer this question, I suggest
that looking at the original expression of the (GMR28G05::TauMyc) transgene before replacing
the promoter would be more helpful, by generating a new transgene that has GMR28G05
introduced into the axonal marker TauMyc construct under the control of the robo2 original
promoter.
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Conclusion
I have presented here transcriptional regulation of the robo2 gene in Drosophila CNS.
Screening of 17 Janelia GAL4 transgenic lines by using the GAL4-UAS system yielded six
promising fragments (GMR28F02, GMR28G05, GMR28E07, GMR28B05, GMR28C04 and
GMR28D10). Four of these fragments showed strong expressions, two in the longitudinal
pathway (GMR28F02 and GMR28G05), and the other two showed expression in the midline glia
(GMR28E07 and GMR28B05). Rescue construct for these six fragments in addition to three
fragments generated in our lab (SEG01, SEG02, and SEGO3) showed robo2 expression in
subsets of the longitudinal pathway driven by 6 fragments (GMR28G05, and GMR28F02,
GMR28C04, GMR28D10, SEG02, and SEG03). GMR28G05, and GMR28F02 showed the
strongest expression, and two of the remainder rescue construct transgenes showed robo2
expression in the midline glia driven by GMR28E07, and GMR28B05 with similar expression
levels for both. While putting transgene of a single fragment (putative enhancer) in robo2 mutant
background did not rescue robo2 expression, a combinatorial of two fragments showed a rescue
of the robo2 expression in both midline and longitudinal pathway.
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Chapter three: Using CRISPR/Cas9 system and bioinformatics tools to characterize robo2
enhancers.
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Abstract
Regulatory regions are non-coding DNA sequences that regulate genes transcriptions through
the transcription factors. One of these regulatory regions is an enhancer. Enhancers increase the
transcription of genes and they can be located upstream, downstream, within the introns, or in a
long distance from the gene they regulate. Multiple enhancers might be required to act in
coordination to regulate a gene transcription. Results from the previous chapter suggest that
Robo2 can be led by multiple enhancers. GMR28G05 and GMR28F02 fragments, which led the
strongest expression of robo2 in the longitudinal pathway, are potentially the multiple enhancers
for robo2. To examine this finding, the CRISPR-Cas9 system was used to delete both fragments
separately and together. Change in robo2 expression in the longitudinal pathway will give insight
into the role of these fragments. Also, knowing which transcription factor(s) might bind to the
above fragments would help us to unveil the role(s) of these fragments regarding to robo2
transcription. Thus, bioinformatics tools and literature were utilized in the second part of this
chapter. I found three promising transcription factor candidates (Hb9, Nkx6.1 and Lhx2) that
potentially bind GMR28G05 and GMR28F02 with the following DNA consensus binding motifs
(TAATTA), (TTAATTG), and (TAATTA), respectively. These findings may open new avenues
to understand the transcription regulation of robo2 regarding its enhancers.
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Introduction
Understanding genetic variations and their association with causing diseases is important,
especially for human health. While studies show that a mutation in the protein-coding gene
regions can lead to most pathogenic alterations, mutations in the non-coding sequences can affect
gene regulation and pathways involved in specific diseases such as cancer (M. B. Patel & Wang,
2019). Intron sequences make up about 25% of the human genome, which is 4∼5 times the size
of exons (Sakharkar et al., 2004). Introns can play a protective role for the eukaryotic genome
sequences by occupying 40% of the total length of the gene and eventually most of the random
mutations will occur in the intron regions, keeping the protein sequences and functions safe.
However, a mutation in the intronic regions can lead to tumorigenesis by affecting the splicing in
direct manner and causing malignant transcript isoforms, making introns crucial for the cell
health. Introns can impact protein variety by affecting alternative splicing and Drosophila Dscam
gene represents an excellent example of increasing protein variety. It can produce more than
38,000 isoforms that can be produced from alternative splicing (Pan et al., 2008). Furthermore,
introns have a potential effect in enhancing gene expression and researchers prefer including
introns in designing constructs in order to guarantee a higher level of expression(Clark et al.,
1993). Studies in mammals and yeasts confirm that genes with their introns show a higher level
of expression than those without introns (Juneau et al., 2006; Shabalina et al., 2010). Although
current genome-wide discovering revealed a wide number of functional genes in the DNA
coding regions, the functional elements in the non-coding sequences of human genome are not
fully uncovered. Due to the critical role of non-coding sequences of human genome in different
aspects, such as being involved in the transcription factor binding, chromatin states, and
modification resulted from epigenetics, more studies would be required (Li et al., 2014).
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This chapter focuses on testing the effect of putative enhancers located on the first intron of
the robo2 gene on its protein expression. The results from the previous chapter suggested that
multiple enhancers are necessary for leading the robo2 expression in the longitudinal pathway
and two fragments (GMR28G05 and GMR28F02) located in the first intron of the robo2 gene
showed the strongest expression of robo2 in the lateral pathway. However, it is not known
whether the robo2 expression will be affected by the absence of these two fragments. In this
chapter, I used CRISPR-Cas9 to make deletions in a region of the robo2 first intron. I deleted
GMR28G05 fragment (3.8 Kb) and GMR28F02 fragment (3.7Kb). Both GMR28G05 and
GMR28F02 fragments and in between fragment, the total DNA length was 11.5Kb, were deleted
as well and the robo2 gene expression will be monitored.
CRISPR-Cas9 as a precise tool in genome editing
Clustered regularly interspaced short palindromic repeats (CRISPR-Cas9) is the most recent
discovery in genome editing technology that enables researchers to precisely manipulate the
DNA sequence of any genome. It was first discovered as a family of the DNA sequence belongs
to bacteriophages that previously infected prokaryotes. Prokaryotes used these DNA sequences
to detect and destroy any DNA identical to the bacteriophage during successive infections. For
this reason, these sequences are considered a defense system that prokaryotes use against viral
infection. (Barrangou, 2015). Cas 9 is an enzyme guided by the guide RNA (gRNA) sequence to
recognize and cleave the DNA sequence that is complementary to the gRNA sequence. Since
then CRISPR-Cas9 has been the cornerstone of gene-editing in different organisms. (Zhang et
al., 2014). It provides a vigorous multifunctional gene-editing tool, allowing researchers to
accurately manipulate genome elements, and facilitating of targeting genes. This technique has
been utilized in both molecular biology and disease treatment. It was successfully used to target
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important genes in many organisms and cell lines. (https://www.neb.com/tools-andresources/feature-articles/crispr-cas9-and-targeted-genome-editing-a-new-era-in-molecularbiology).
Unlike alternative genome editing technologies such as zinc-finger nuclease (ZFNs) and
transcription activator-like effector nucleases (TALENs), which depend on the use of
customizable DNA-binding protein nucleases, The CRISPR-Cas9 system has a discernible
benefit over these technologies. Using RNA-based CRISPR provides simplicity and flexibility
for genome editing. For this reason, CRISPR has revolutionized biomedical research, and
become one of the most essential approaches for genome engineering (Kim et al., 1996; Smith
et al., 1999; Bibikova et al., 2001; Boch et al., 2009; Moscou & Bogdanove, 2009; Christian et
al., 2010; Tianfang Ge et al., 2016).
The Cas9 mediated genome editing system requires only three components:1. Cas9 that can
be available as a gene, mRNA, or purified protein, 2. gRNA, which can be supplied as an RNA
or transcribed from the DNA template in vivo. 3. DNA donor holding the target sequence which,
in turn, involves a novel sequence to be inserted or indels.
In the CRISPR-Cas9 system, cas9 makes a DNA double-strand break (DSB) and the next step
involves repairing the DSBs, which occurs by one of two major repair pathways (Figure 3.1): 1.
The non-homologous end-joining (NHEJ) pathway, which considered an efficient but errorprone pathway, and 2. The homology-directed repair (HDR) pathway, the less efficient but highfidelity. Unlike HDR, NHEJ does not require a DNA template with homology to the sequences
flanking the DSB. NHEJ, therefore, generates insertions or deletions during DSB repair. The
efficiency of NEHJ is higher than HDR and the repairing time is shorter (tens of minutes). NHEJ
is useful if there is a requirement of making a null allele (Knockout) in the gene of interest.
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HDR, on the other hand, requires a presence of the DNA template homology to the DSB location
flanking sequence. As a result, repairing the broken DNA strands occurs in an error-free manner.
While NHEJ is active throughout the cell cycle, HDR can be used by the cell only if the
homology DNA is present in the nucleus in specific phases (most likely G2 and S phase) of the
cell cycle. In addition to the cell cycle, the efficiency of HDR depends on the concentration of
the DNA that exists during repairing time, the homology arm length of the donor DNA, and the
efficiency of the endogenous repair systems. HDR is used to make an insertion (Knockin) in the
gene of interest (Figure 3.1)(Lin et al., 2014; Iliakis et al., 2004; Hasty et al., 1991; WolfDietrich Heyer, 2008; Pardo et al., 2009). In this chapter, the CRISPR-Cas9 approach was used
to create a deletion in robo2 regulatory regions including GMR28G05 and GMR28F02
separately or together by non-homologous end-joining in Drosophila.
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Figure 3.1: CRISPR/cas9 Genome Editing Mechanism. The complex of Cas9 and gRNA
binds with the DNA close to the PAM sequence. Cas9 generates a DNA double-strand
break (DSB) 3-4 bp upstream of the PAM sequence, this DSB can be repaired via NHEJ,
which might result in insertion or deletion or in a frameshift that causes gene knockout, or
HDR, which can cause gene knockin if the DNA donor is provided with homology in the
ends. (Image adapted from https://www.genscript.com/using-crispr-for-genomeediting.html).
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Transcription factors and gene expressions
Generally, the transcription of genes is controlled by different ways and one of them is the
interaction of the transcription factors to specific DNA sequences. Sometimes these proteins are
encoded by genes that are in a different place of the genome from the genes that they regulate;
therefore, they are called trans-acting factors. When these proteins bind to their regulatory
elements of the same DNA fragment that has the gene that they regulate, these regulatory
elements are called cis-acting factors. The transcription of genes is mediated by the RNA
polymerase enzyme that plays an important role in catalyzing the RNA synthesis and this RNA
is complementary in sequence to the DNA template. There are three RNA-polymerases in
eukaryotes: RNA polymerase I (Pol I),which is responsible for transcribing genes that encode the
ribosomal RNA, RNA polymerase II ( Pol II or RNA PII), which transcribes genes into mRNA,
and RNA polymerase III(Pol III) that transcribes genes that encode the tRNA and the small
nuclear RNA (Kadonaga, 2004).
Pol II is a large protein with a molecular mass of 600 KDa consists of 10-12 subunits. This
protein can transcribe RNA from DNA. Despite its capability to catalyze mRNA synthesis, Pol II
cannot bind to the DNA and initiate the transcription by itself without the assembly of specific
proteins called general transcription factors. There are six general transcription factors that are
important for class II genes transcription. These factors are TFIIA, TFIIB, TFIID, TFIIE, TFIIF,
and TFIIH. These transcription factors by assembling with the Pol II make the pre-initiation
complex or the basal transcriptional machinery and the latter assembles with the promoter region
of the DNA (Kadonaga, 2004; Hahn, 2005).
DNA promoter consists of many regions that are incorporated in the transcription process. A
TATA box region, which is essential for recognizing the RNA Pol II, an initiator ( Inr) box,
81

which consists of a stretch of nucleotides sequence in the DNA from where the transcription
lunches, and the upstream controller elements region that binds to the RNA Pol II (Schramm &
Hernandez, 2002).
RNA Pol II should interact with the DNA before the transcription initiates, and for this
interaction to happen, general transcription factors should bind to TATA box and Inr. The first
general transcription factor that binds to the DNA template is TFIID (Kadonaga, 2004; Nikolov
& Burley, 1997). TFIID consists of a TATA-binding protein (TBP), a highly conserved protein
that plays a vital role in all eukaryotic transcription. TBP has an antiparallel β-sheet that can sit
on the minor groove of the DNA and make a conformational changing in the DNA doublestrand. TBP has also an α-helix domain, which is considered the recognition motif between the
transcription factor and the DNA by binding to the DNA major groove. After binding to the
DNA, TFIID starts to recruit TFIIB that can bind to TBP and GC- rich DNA sequence
downstream of TATA motif at the same time. The TFIIB-TBP-DNA complex gives the order for
the RNA Pol II to start the transcription and choose one of the two strands of the DNA to be the
template. Binding the N- terminal domain “zinc ribbon “(a cystin-rich, zinc-binding region) of
TFIIB to the RNA Pol II activates the recruitment of the RNA pol II and this, in turn, pulls the
initiation complex to the RNA Pol II surface and the DNA, in this case, will easily reach to the
active site. For the transcriptional initiation to start, it requires TFIIF that plays an active role in
the formation of strong complex with the RNA Pol II, which recruits TFIIE, and TFIIE, in turn,
helps to recruit TFIIH, the most complex structure amongst all other general transcription
factors. The complex of the RNA Pol II, core promoter, and general transcription factors is called
the pre-initiation complex (PIC). TFIIH has the ATPase/ helicase subunit, which hydrolyzes the
ATP to melt the promoter (unwinding the DNA double-strands) by TFIIE assistance. TFIIF
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captures the non-template DNA strand while the template strand goes to the RNA Pol II active
site. (Hahn, 2005; (Kadonaga, 2004)
Transcription factors and enhancers
Since basal transcriptional machinery of general transcription factors and the RNA Pol II are
not sufficient for gene transcription, additional proteins are needed to facilitate this process, and
these proteins are called transcription factors that are able to identify and bind to the gene
enhancers. The DNA looping model proposes that the basal transcriptional machinery assembles
with the gene promoter and the transcription factors bind to the gene enhancer. looping out the
DNA intervening allows the transcription factors to physically interact with the basal
transcriptional machinery and this interaction will energize gene transcription. The interactions
between the amino acid side chains of transcription factors and the DNA bases of purine and
pyrimidine determine the accuracy of transcription factor binding to the DNA through the noncovalent hydrogen bonds between the amino acids and the DNA bases. The transcription factor
peptide can bind to the major groove of the DNA (Rohs et al., 2010). This interaction between
the transcription factor and the DNA may happen electrostatically by the formation of the salt
bridge with anionic phosphate groups (Luscombe, 2001).
Transcription factors are grouped in families based on sequence conservation and tertiary
structure determined from X-ray crystallography and nuclear magnetic resonance spectroscopy.
Members of each family have the same certain structural motifs for the DNA binding. These
structures are zinc finger, basic zipper (Bzip), helix-turn-helix (HTH), basic helix-loophelix(bHLH), and β-sheet. These motifs are composed of a specific tertiary protein structure in
which its α-helix component interacts with the DNA major groove. Transcription factors are
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capable of recognizing a short sequence of about 12 base pairs in most cases (Boron &
Boulpaep, 2005) (Table 3-1).
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Table 3.1 Transcription factors and the DNA sequences they recognize

Examples of specific transcription factors

Factor

Structural type

Recognition sequence

Binds as

SP1

Zinc finger

5'-GGGCGG-3'

Monomer

AP-1

Basic zipper

5'-TGA(G/C) TCA-3'

Dimer

C/EBP

Basic zipper

5'-ATTGCGCAAT-3'

Dimer

Heat shock factor

Basic zipper

5'-XGAAX-3'

Trimer

ATF/CREB

Basic zipper

5'-TGACGTCA-3'

Dimer

c-Myc

Basic helix-loop-helix

5'-CACGTG-3'

Dimer

Oct-1

Helix-turn-helix

5'-ATGCAAAT-3'

Monomer

NF-1

Novel

5'-TTGGCXXXXXGCCAA-3'

Dimer

(G/C) = G or C
X = A, T, G or C

Adapted from (Boron & Boulpaep, 2005)
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Predicting transcription factors that bind specific sites
Characterizing of the transcription factor binding sites (TFBSs) on the genomic DNA has
become a big challenge after the publication of the complete sequence of the human genome. To
identify the complete set of functional elements in these sites, many approaches have been
utilized including experimental and computational comparisons of associated genomes.
Transcription factors and the DNA sites that they bind are the most critical elements in any
genome. The transcriptional regulatory network resulted from the interaction between the TFs
and the DNA provides a big insight into the potential functions of the genes that are regulated by
these DNA binding sites. Multiple methodologies have been used to detect the DNA sites that
TFs bind to, such as gel shift assay, and Southern blotting of the DNA and proteins. However,
these approaches are not efficient in terms of the time that they consume and being unable to
cover the whole genome. Therefore, another technique was used later which is called SELEX
(Systematic Evolution of Ligands by Exponential Evolution) to find the high-affinity binding
sequences which is modified then to the genomic SELEX that uses the genomic library for the
selections. In recent times, CHIP-chip assay, the highest throughput technique, is broadly used to
identify genomic TFBSs in vivo.
In silico, many computational methods have been used to predict the proteins that can bind to
the DNA and a method called a position weight matrix (PWM), or a position-specific scoring
matrix (PSSM) is the most common method used to represent the degenerate sequence preferring
of the DNA binding protein. In this computational method, the elements of PWM represent the
scores that reflect the frequency of observing of a certain nucleotide at a certain position of
specific or putative TFBSs. Despite the high accuracy in identifying of TF binding in vitro, the in
vivo binding of these TFs might not occur or might not represent a direct regulatory function that
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the in vitro binding shows. However, this defect does not belong to the computational
techniques, but it is related to some biological facts, such as chromatin structures and
competition on the binding site (Bulyk, 2004).
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Material and methods
gRNA design
All the target sequences were identified using the National Center for Biotechnology
Information (NCBI) website to direct cas9- mediated cleavage to target the GMR28G05 and
GMR28F02 regions. CRISPR target finder website was used to design gRNAs with 100% offtarget cleavage (http://tools.flycrispr.molbio.wesc.edu/targetfinder). The gRNAs were cloned
into PCFD4 plasmid (port et al,2014) (Appendix 5). The following primers (Appendix3, table 2),
800 and 801 primers for GMR28G05, and 798 and 799 for GMR28F02, and 798 and 801 primers
for GMR28G05+ GMR28F02, were annealed by PCR. The PCR products were inserted into
BbSI- digested PCFD4 backbone using Gibson assembly Ultra Kit (Cat no.:GA1200-10). In the
case of GMR28G05 gRNA an additional G nucleotide was added to the 5՛ end of the
GMR28G05 gRNA target sequence to facilitate the transcription from the U6-1 promoter
(Addgene plasmid no. 49411). The resulting plasmid was cloned into E-coli competent cells.
Preparing the DNA for injection
A mixture of cas9 encoding the DNA plasmid (Appendix 5) and two gRNAs encoding
plasmids for each deletion was used in a concentration of 500ng/µl for cas9 and 250ng/µl
plasmids in a total volume of 20 µl. 2 µl of filtered food dye diluted 1:100 in distilled water was
added to the 20 µl of the injection mixture. Needles used for the injection were made up of
capillary tubes of 100 mm length, 1.0 mm outside diameter, 0.56 mm inside diameter
borosilicate glass capillaries with filament (# 1 B100F-4 World precision Instruments Inc,
Sarasota, FL). Capillaries were pulled by using P-100 Faming/ Brown Micropipette Puller
(Sutter Instruments. Novato, A). A program with the following parameters was used to pull the
needles: Heat 590, Pull 115, Velocity 15, Time 250, Pressure 600, and Ramp 590. Needles were
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loaded with 1 µl of injection mix using an Eppendorf loader tip (Eppendorf), fitted into a needle
holder attached to a syringe to facilitate injection, and controlled by a micromanipulator
(Figure.3.2). The tips of the needles were opened with a micro-dissection scissor as needed.
Embryos injection
Fly stocks were amplified in advance to get enough eggs for injection. Approximately 300
mature flies of genotype roborobo2/robo2robo2 were transferred to an egg-lay cage with an apple
juice plate incubated at 25˚C for at least one day prior to the injection day to get the flies
accustomed. Embryos were collected on the apple juice plate each 20-30 min with the apple juice
plate change each time the embryos were collected and yeast paste was spread in the center of
the plate. The collected embryos were rinsed with water, and dechorionated for 60 s in 6%
sodium hypochlorite, washed with tap water and lined up on a slide with a coverslip and covered
with extra virgin organic olive oil. The slide with the embryos was moved to a Nikon TS 100
inverted microscope equipped with a micromanipulator. Embryos were injected by moving the
stage to insert the needle in the posterior end of the embryo (Figure 3.2.A-C). The pressure was
applied to the syringe until the DNA moved into the embryos which is monitored through the
blue food dye. Injected embryos were thoroughly washed with ethanol 95% to remove the olive
oil, then the ethanol was washed off with distilled water. The excess water on the coverslip was
drained by applying the coverslip’s edge onto a clean tissue. The coverslip was transferred into a
food vial, pushed down into the food with the embryos anterior up until the embryos touched the
food, so when the larvae hatch, they will crawl into the food. The marked food vials were placed
into a humid chamber at 25 ˚C for (24-48 hr), or until the larvae hatch.
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B
A

C

Figure 3.2. Drosophila embryo injection setup. A and B, (left, embryos), (right, injection
needle). C. Drosophila embryos are injected by moving the stage to insert the needle in
the posterior end of the embryo.
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PCR analysis of the CRISPR-Cas9 deletions
After injected embryos have reached adulthood, the G0 flies were crossed 1:3 to Sco/CyOwg
virgins. After 3 days of crossing, adults were removed and screened with PCR using primers
811, 812 for GMR28G04, 813, 814 for GMR28F02, and 811,814 for GMR28G04+ GMR28F02
(Appendix 3, Table 2). The progeny of positive PCR F1 will be collected to make a stock.
In silico studies for the transcription factors of robo2 first intron putative enhancers
Depending on the predicted transcription factors taken from the literature, I used two
bioinformatics websites JASPAR 2020 (http://jaspar.genereg.net/) and the footprint database
(FootprintDB) website (http://floresta.eead.csic.es/footprintdb/index.php?search_entries) to
investigate whether these candidate transcription factors can bind to robo2 putative enhancers
(GMR28G04 and GMR28F02). The candidate transcription factors from literature were
submitted through JASPAR 2020 website to provide the ID numbers of the nominated
transcription factors. These ID numbers were utilized to find the predicted consensus regions by
using the FootprintDB website and the DNA logo that represents the probability of the
nucleotides in each DNA transcription factor binding site. These consensus regions were aligned
with robo2 fragments sequences using Clustal Omega
(https://www.ebi.ac.uk/Tools/msa/clustalo/) to find the regions where these sequences are in
robo2 fragments.
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Results and Discussion
In this chapter CRISPR/Cas9 was utilized to delete GMR28G05 and GMR28F02 fragments
separately or together by using non-homologous end-joining (NHEJ). gRNAs were designed and
inserted into PCFD4 plasmid. The constructed plasmids were confirmed by PCR (Figure 3.3)
and sequencing (Figure.3.5A-C), then cloned in E. coli competent cells. These plasmids were
injected alongside with Cas9 expressing plasmid into flies that have CRISPR allele where the
genomic robo2 was replaced by the HA-Robo2. Injected embryos were raised, crossed to
Sco/CyOwg and offspring were collected for screening to identify the deletion in these
fragments. A total of 666 embryos were injected with a mix of the GMR28G05 gRNA and the
Cas9 plasmids, 216 embryos were injected with a mix of the GMR28F02 gRNA and the Cas9
plasmids, and 226 embryos were injected with a mix of the GMR28G05+GMR28F02 gRNA and
the Cas9 plasmids (Table.3.2). Of the injected embryos, 21 survived of GMR28G05, 7 survived
of GMR28F02, and 4 survived of GMR28G05+ GMR28F02 to adulthood. After crossing to
Sco/CyOwg, potential founders of each group (GMR28G05, GMR28F02, and
GMR28G05+GMR28F02) produced offspring of 16, 5, 3, respectively. The injection survival
rate was 3.15%, 3.24%, and 1.76% of injected embryos to adulthood for GMR28G05,
GMR28F02, and GMR28G05+GMR28F02 respectively and fertility rate found for those adults
was 76.1% for GMR28G05, 71.4% for GMR28F02, 75% for GMR28G05+GMR28F02
(Table.3.2).
In general, the results of injection show that there is a low survival rate which, in turn,
reduced the efficiency of the deletion. The rate of survival is comparable with another graduate
student in our laboratory. Besides the low rate of survival of injected embryos, SARS-CoV-2
(COVID-19) pandemic has negatively affected my research. The university closure during the
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pandemic has stopped my research and I was not able to test most of the injected flies. In future
studies, I suggest that additional trials with improved techniques such as electroporation for
chorionated and dechorionated Drosophila embryos might fix this pitfall.
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Table.3.2. CRISPR Data for Drosophila embryo injection.
Injection mix

No. of injected %(no.) adult G0 %(no.) fertile G0 %(no.) G0
embryos
survival
survival
founders

GMR28G05

666

3.15(21)

76.1(16)

-

GMR28F02

216

3.24(7)

71.4 (5)

-

GMR28G05+ GMR28F02

226

1.76(4)

75 (3)

-
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A

pAct-cas9

28G05+28F02 gRNA in PCFD4

28F02gRNA in PCFD4

28G05gRNA in PCFD4

B

500700-

Figure 3.3 gRNA and CAS9 vectors confirmation. A.2µl of miniprep DNA of gRNAs
in PCFD4 vector (GMR28G05 gRNA in PCFD4 595bp, GMR28F02 gRNA in PCFD4
595bp, and GMR28G05+GMR28F02 gRNA in PCFD4 600bp). B. 2µl of miniprep of
pAct-cas9 vector 700bp.Plasmid sizes compared to 1Kb Plus DNA Ladder from
Invitrogen (Carlsbad, CA).
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Figure3.4. Cloning tandem gRNA expression plasmid with PCFD4
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Figure 3.5A Schematic construction of GMR28G05 guide RNA in pCFD4.The pCFD4
plasmid was used to deliver the 5’ and 3’ gRNAs. Oligo 800 was used for the fwd. prime
and 801 for the rev primer. gRNAs are under the control of U6:1 and U6:3 promoters
(Addgene plasmid 49411 expression in PCFD4).
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Figure 3.5B Schematic construction of GMR28F02 guide RNA in pCFD4.The pCFD4
plasmid was used to deliver the 5’ and 3’ gRNAs. Primer 798 was used for the fwd.
primer and 799 for the rev primer. gRNAs are under the control of U6:1 and U6:3
promoters (Addgene plasmid 49411 expression in PCFD4).
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Figure 3.5C Schematic construction of GMR28G05+GMR28F02 guide RNA in
pCFD4.The pCFD4 plasmid was used to deliver the 5’ and 3’ gRNAs. Oligo 798 was used
for the fwd. primer and 801 for the rev primer. gRNAs are under the control of U6:1 and
U6:3 promoters (Addgene plasmid 49411 expression in PCFD4).
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Transcription factor candidates that can potentially bind to robo2 putative enhancers
(GMR28F02 and GMR28G05)
1. Hb9 transcription factor (exex in Drosophila)
Hb9 transcription factor (exex), also known as Extra-extra, Q9VSC2_DROME, and
RE39081p, in Drosophila embryos, can regulate axon guidance by acting upstream of robo2 and
robo3. This transcription factor is necessary for robo2 expression in ventrally extending motor
neurons. In Hb9 mutants, restoring Robo2 activity plays an important role in motor axon defect
rescue. Hb9 can regulate Robo2 over its conserved repressor domain and acts in parallel with
NKX6.1. Robo2 and Robo3 play a key role as Hb9 effectors to regulate the nervous system
development and Hb9 can regulate the mediolateral positioning of axons through Robo2 and
Robo3. A previous study accomplished on Hb9+ cells that express Robo2 in which robo2
expression was scored, robo2 mRNA expression shows a decrease in Hb9+ mutant (Landgraf et
al., 1997; Santiago et al., 2014).
To examine whether Hb9 could be a transcription factor that regulates robo2 expression by
binding GMR28F02 and GMR28G05, I used a combination of two bioinformatics websites
(JASPAR 2020, and FootprintDB, http://floresta.eead.csic.es/footprintdb/index.php) as described
in the materials and methods section. I found that the specific binding motif of Hb9 (TAATTA)
is found at two locations of GMR28F02 and three locations of GMR28G05 (Figure.3.6)
These results were expected because Robo2 has been detected as an effector of Hb9 in motor
neurons. Also, both Robo2 and Hb9 mutants share the same defects in the lateral positioning.
Together, these data propose that Hb9 might regulate the medial and the lateral positions of a
subset of interneurons by affecting Robo2. Apterus axon in the wildtype embryos projects its
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fascicle in the medial FasII pathway on both sides of the midline. robo2 overexpression in the
Apterus neurons shifts their axons laterally (Evans & Bashaw, 2010; Rajagopalan et al., 2000b;
Simpson et al., 2000a). Overexpression of Hb9 shows a similar phenotype by shifting apterus
axons laterally. Importantly, overexpression of Hb9 in apterus neurons results in robo2
upregulation significantly. In robo2 mutants (when both copies of robo2 were removed),
overexpression of Hb9 led to full suppression in Hb9’s gain of function phenotype while Apterus
axons still look like a wildtype (Santiago et al., 2014), which means that ectopic expression of
Hb9 enhances robo2 expression and this robo2 expression, in turn, affects mediolateral
positioning axons.
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A.

B.
F02 nt 250-255:
CCCATTTTTCCTCAGCACTTAATTACGCTCATTTGGCATATATGCTCTTCATTTG
F02 nt 2770-2775:
TATGTACATTTTCTTACATTAATTATAAAGTAACTATTTTTTTTACAATACCAGT
G05 nt 1716-1721:
GACATTCCATTTTCGCTATAATTAATAAACACACGGCAAAACAATTTATCAGTT
G05 nt 2456-2461:
CTGCCAAAACGAACAACATAATTACCGTTAAGAATTGCGAGTTGCAACATCAGC
G05 nt 3527-3532:
TGCGGAGCCAAAGTTGGCTAATTAGCTATGCAAACTATGAGATACACAACACAA
Figure 3.6. Predicted DNA binding motif sequence of Hb9 in GMR28F02 and GMR28G05. A.
Logo of the DNA binding motif sequence of Hb9 shows the probability of nucleotides in the
sequence (adapted from http://floresta.eead.csic.es/footprintdb/index.php). B. locations and
numbers of the DNA binding motif sequence of Hb9 in GMR28F02 and GMR28G05. (F02 and
G05 refer to GMR28F02 and GMR28G05, respectively).
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2.Nkx6.1
NKX6.1, Also known as NKX6A and HGTX, is one of the homeodomains transcription
factors that belong to the NK family whose genes products are involved in specifying of the cells
fate and differentiation in specific tissues. It is expressed in the ventral part of the neural tube of
the mouse and chick embryos (Jørgensen et al., 1999). It has an important role in the spinal cord
and motor neurons specification in addition to its role in axon projecting and muscle targeting in
motor neurons (Sander et al., 2000; Thaler et al., 1999; Garcia & Jessell, 2008; Arber et al.,
1999; Vallstedt et al., 2001). In Drosophila, NKx6.1 is expressed in embryonic motor neurons
that extend to the lateral or ventral body wall muscles and they are necessary for motor axons
that project ventrally (Broihier & Skeath, 2002; Broihier et al., 2004; Odden et al., 2002). In
addition to the motor neurons, NKx6.1 has shown expression in a subset of interneurons.
Drosophila NKx6.1 can act as an activator or repressor; however, none of these activities were
tested in vivo (Syu et al., 2009).
To test the binding ability of NKX6.1 on GMR28F02 and GMR28G05 fragments, I followed
the same procedure as in the previous transcription factor (Hb9). I found two locations of the
consensus sequence (TTAATTA) of NKX6.1 in GMR28F02 while one consensus sequence
(TTAATTG) of NKX6.1 was matched in GMR28G05 (Fig 3.7. B).
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A.

B.
GMR28F02 nt 250-256:
CCCATTTTTCCTCAGCACTTAATTACGCTCATTTGGCATATATGCTCTTCATTTGT
GMR28F02 nt 2770-2776:
TATGTACATTTTCTTACATTAATTATAAAGTAACTATTTTTTTTACAATACCAGT
GMR28G05 nt 2562-2568:
CAGAACGTTTTGGGCTCCTTAATTGCCATTGGTAGACTCCATTTGGCATGGCCGC
Figure 3.7. Predicted DNA binding motif sequence of NKX6.1 in GMR28F02 and GMR28G05.
A. Logo of the DNA binding motif sequence of NKX6.1 shows the probability of nucleotides in
the sequence (adapted from http://floresta.eead.csic.es/footprintdb/index.php). B. locations and
numbers of the DNA binding motif sequence of NKX6.1 in GMR28F02 and GMR28G05. (F02
and G05 refer to GMR28F02 and GMR28G05, respectively).
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Homeodomain proteins compared to other transcription factors are indistinctive in their
specificity to bind the DNA. These proteins recognize the consensus sequence ATTA, the DNA
sequence that can be recognized by many different homeodomain proteins in vitro (Gehring et
al., 1994; Mannervik, 1999). Since many gene promoters contain the same core motif “TAAT”
in their sequences, determining the downstream target becomes more complicated. Therefore,
knowing the flanking sequence of this core motif is of utmost important goal to reduce the
binding affinity. A study accomplished by (Jørgensen et al., 2007) shows that using in vitro
binding site selection reveals identifying the DNA sequence of NKx6.1 binding site of
TTAATTG/A .
Another study conducted by (Mirmira et al., 2000) showed an approach to identify the
optimal DNA binding by NKX6.1 homeodomain. The coding sequence of NKX6.1 was fused to
6 tandem histidine residues (His6) at N- terminus and expressed in E-coli, then the expressed
NKX6.1 protein was purified and used to select for the DNA binding from a library of 55 bp
nucleotides that have a central region of 15 random nucleotides. After isolation of protein and its
bound DNA, the selected DNA sequence was amplified by PCR and used for several selection
rounds. Multiple PCR product sequences were aligned to give the consensus sequence of
TTAATTAC. This study comes in agreement with the previous study done by Jorgensen et al
with an addition of one nucleotide (C) at the 3՛ of TTAATTA (TTAATTAC) sequence motif,
which makes it more specific for binding specific transcription factors.

105

3. Lhx2 transcription factor
Lhx2is a transcription factor that regulates numerous developmental aspects in different
embryonic stages including proliferation control of progenitor, specification of the cell fate of
post-mitotic progeny, cell differentiation, and axon pathfinding (Chou & Tole, 2019). Lhx2 is
also known as ap; GJ14977; apterous; GJ14977-PA; GJ14977-PB. According to (Subramanian
et al., 2011), Lhx2 plays a central role in regulating the neuron-glia cell fate decision in the
hippocampus. (Marcos-Mondéjar et al., 2012) showed that robo2 mRNA expression is repressed
by the LIM-HD transcription factor Lhx2 in postmitotic thalamic neurons. Lhx2 overexpression
in rostral (rTh ) and intermediate (iTh ) thalamic neurons results in an improper invasion of
Thalamocortical axons (TCAs) in improper regions of the hypothalamus which, in turn,
decreasing the number of axons that reach the cortex in a process similar to that of the absence of
Slit/robo signaling (Bagri et al., 2002; López-Bendito et al., 2007).
In silico studies that I conducted using bioinformatics websites (explained in materials and
methods), I found that the DNA motif (TAATTA) of Lhx2 (Fig3.8. A) can bind two locations of
GMR28F02 and three locations of GMR28G05 (Fig3.8. B).
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A.

B.
GMR28F02 nt 250-257:
CCCATTTTTCCTCAGCACTTAATTACGCTCATTTGGCATATATGCTCTTCATTTGT
GMR28F02 nt 2770-2776:
TATGTACATTTTCTTACATTAATTATAAAGTAACTATTTTTTTTACAATACCAGT
G05 nt 1716-1721:
GACATTCCATTTTCGCTATAATTAATAAACACACGGCAAAACAATTTATCAGTT
G05 nt 2456-2461:
CTGCCAAAACGAACAACATAATTACCGTTAAGAATTGCGAGTTGCAACATCAGC
G05 nt 3527-3532:
TGCGGAGCCAAAGTTGGCTAATTAGCTATGCAAACTATGAGATACACAACACAA
Figure 3.8. Predicted DNA binding motif sequence of Lhx2 in GMR28F02 and GMR28G05. A.
Logo of the DNA binding motif sequence of Lhx2 shows the probability of nucleotides in the
sequence (adapted from http://floresta.eead.csic.es/footprintdb/index.php). B. locations and
numbers of the DNA binding motif sequence of Lhx2 in GMR28F02 and GMR28G05. (F02 and
G05 refer to GMR28F02 and GMR28G05, respectively).
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It was expected to find several hits of the DNA binding motif of Lhx2 in GMR28F02 and
GMR28G05 sequences. It has been involved in directly regulating Robo2 function in
commissural neurons of the developing spinal cord of mice by binding to specific regulatory
sequences of robo2. The phylogenetic footprinting analysis of regions 20kb upstream and 70kb
downstream of robo2 transcription initiation site shows four putative robo2 regulatory regions
that can bind Lhx2 with evolutionarly conserved regions, and CHIP assay shows that Lhx2 binds
significantly to the robo2-region 3. These results indicate that Lhx2 acts as a transcriptional
regulator for robo2 expression in thalamic neurons of mice when it binds to the regulatory region
in the robo2 gene in vivo. Putative Lhx2 DNA binding region shows 6bp consensus sequences in
robo2. CHIP assays experiments show a specific enhancer region (TAATTA) in robo2 is the
target sequence that Lhx2 binds in the spinal cord of E12-5 embryonic stage of thalamic tissue in
vivo in genomic rat, mouse, chimpanzee, macaque, human, and dog (Marcos-Mondéjar et al.,
2012).
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Conclusion
To sum up, this chapter presents the importance of introns in gene expression and how
deleting single or multiple regulatory regions might affect robo2 expression. The CRISPR/Cas9
system was utilized to make a deletion of GMR28G05 and GMR28F02 from robo2 first intron
separately or together. The deletion efficiency was severely reduced due to the low injection
survival rate. Besides, the SARS-CoV-2 (COVID-19) pandemic has stopped my research and as
a result many of the injected flies have not been tested for the deletion. With additional trials and
using more effective techniques such as electroporation, it will be possible to get these fragments
deleted and see the effect of this deletion on robo2 expression. The second part of this chapter
focuses on predicting the transcription factors that can potentially bind to robo2 putative
enhancers. Both bioinformatics tools and literature were utilized to find these predicted
transcription factors. Hb9 (exex in Drosophila) with its consensus binding motif to the putative
enhancers (TAATTA), Nkx6.1 with (TTAATTG) sequence, and Lhx2 with (TAATTA) binding
motif were transcription factor candidates that can potentially bind to robo2 putative enhancers
GMR28F02 and GMR28G05.
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Chapter Four: Conclusions and future directions
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Robo2 is a transmembrane protein that regulates three distinct roles in directing axon guidance
in Drosophila central nervous system (CNS). These different roles of Robo2 depend in part on its
distinct functional domains and on the dynamic transcription in different subsets of cells through
embryogenesis in another part. Robo2 structural and functional domains in Drosophila were
studied comprehensively in the previous years. However, little is known about the transcriptional
regulation of robo2. This study focuses on testing multiple regions in and around the robo2 gene
that could potentially be enhancers for robo2 in Drosophila. To find the robo2 putative enhancers,
seventeen transgenic lines created by Janelia Research Center were utilized. Each line has one
fragment of robo2 predicted enhancer inserted upstream of the yeast transcriptional activator
GAL4. The seventeen lines were crossed to another transgenic line containing a GAL4 responsive
GFP (UAS-TauMycGFP) to create a protein reporter system. Six promising enhancer candidates
(GMR28F02, GMR28G05, GMR28C04, GMR28D10, GMR28B05, GMR28E07) from the
seventeen transgenic lines were found. Among these fragments, GMR28F02 and GMR28G05
showed strong expression in the longitudinal pathway and two other fragments (GMR28E07 and
GMR28B05) showed strong expression in the midline glia. To ensure the above fragments enhance
the robo2 gene expression, I have created rescue construct transgenic lines for these six fragments
in addition to three fragments created in our lab (SEG01, SEG02, and SEG03). All nine fragments
were introduced into the HA-Robo2 reporter transgene. robo2 showed an expression in all these
fragments except SEG01, and GMR28F02 and GMR28G05 were the strongest expression. To
further investigate whether GMR28F02, GMR28G05 fragments can rescue robo2 expression, I
introduced these fragments separately or together into robo2 mutant background. The combination
of two fragments showed better rescue of robo2 expression in the mutant background compared
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to a single fragment. These results suggest that multiple enhancer regions might be required to
restore robo2 full expression.
I also generated and characterized an equivalent set of robo2 transgenic lines that express the
axonal marker TauMyc instead of robo2. This transgene consists of GMR28F02 or GMR28G05,
and hsp70 promoter followed by TauMyc cDNA. The results showed that unlike GMR28G05,
GMR28F02 drove strong expression in subsets of the lateral neurons, cell bodies, and commissural
axons. Moreover, GMR28F02::TauMyc was introduced into robo2 null mutant background. The
results showed that TauMyc axons that normally express Robo2 in the lateral axons act as cell
non-autonomously in robo2 mutant and they are different from FasII positive axons that are found
on both sides of the midline of Drosophila nerve cord.
The first and the biggest intron of robo2 was hypothesized to play an important role in robo2
expression and our results strongly agreed with that and indicated that GMR28F02 and
GMR28G05 changed robo2 expression. The CRISPR/Cas9 system was utilized to delete these
fragments separately or together. After CRISPR/Cas9 and gRNAs vectors were successfully
constructed and confirmed by the PCR and the DNA sequencing, they were injected into
Drosophila embryos. Most of these embryos were not examined for deletion because of the SARSCoV-2 (COVID-19) pandemic, which stopped my research. Further trials and using more efficient
techniques such as electroporation could facilitate deleting GMR28F02 and GMR28G05
fragments and study the effect of their deletion on robo2 expression.
Additionally, knowing which transcription factor(s) might bind to GMR28G05 and GMR28F02
fragments would help us to reveal the role(s) of these fragments regarding to robo2 transcription.
Thus, bioinformatics tools and literature were utilized. Three promising transcription factor
candidates were found (Hb9, Nkx6.1 and Lhx2) that potentially bind GMR28F02 and GMR28G05
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with the following DNA consensus binding motifs (TAATTA), (TTAATTG), and (TAATTA),
respectively. These findings may open new pathways to understand the transcriptional regulation
of robo2 regarding its enhancers. In the future, using Chromatin Immunoprecipitation (CHIP)
assay with specific antibodies for those predicted transcription factor proteins could provide strong
evidence of how these fragments act as enhancer(s) for the robo2 gene.
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Appendix 2: List of generated stocks
robo2^TauMyc /CyO,wg
(GMR28F02)::TauMyc/ CyO,wg
(GMR28F02)::robo2/ CyO,wg
(GMR28G05)::robo2/ CyO,wg
(GMR28D10)::robo2/ CyO,wg
(GMR28C04)::robo2/ CyO,wg
(GMR28B05)::robo2/ CyO,wg
(SEG01)::robo2/ CyO,wg
(SEG02)::robo2/ CyO,wg
(SEG03)::robo2/ CyO,wg
HSP70[GMR28F02:: TauMyc]/ CyO,wg
HSP70[GMR28G05:: TauMyc]/ CyO,wg
[GMR28F02:: robo2],[ robo2Myc-robo2]/ CyO,wg
[GMR28G05:: robo2],[ robo2Myc-robo2]/ CyO,wg
[GMR28F02:: robo2],[ robo2Myc-robo2]/ [GMR28G05:: robo2],[ robo2Myc-robo2]
robo2123/robo2135
robo2123,[GMR28F02::robo2]/ robo2135,[GMR28F02::robo2]
robo2135/ robo2135
129

robo2135,[GMR28G05::robo2]/ robo2135,[GMR28G05::robo2]
(GMR28G05+ GMR28F02)::robo2
robo2135,[ GMR28G05+ GMR28F02::robo2]/ robo2135,[ GMR28G05+ GMR28F02::robo2]
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Appendix 3. Primers used in this research
Table 1: Primers used to generate rescue construct transgenes.
Primer name

Primer sequence

GMR28F02_F

GATTTCACTGGAACTAGGGGCACTTGGAGTTTTCTCCGTGGACATGACAC

GMR28F02_AscI_R

TGCTATTGAGTGGATGTGGGCGCGCCTGTAGCCATCTCAAGTCTAGAGTCC
TCAGC

GMR28D10_F

GATTTCACTGGAACTAGGGGCACTCCCTCGAATTCCGCACTTTTAACCCTG

GMR28D10_AscI_R

TGCTATTGAGTGGATGTGGGCGCGCCATCATCCGCGCTTCTTAGGCCTCAT
GAGAG

GMR28G05_F

GATTTCACTGGAACTAGGGGGCATGGTTAAGGAGGAACGAAGCACTGCTT
AC

GMR28G05_AscI_R

TGCTATTGAGTGGATGTGGGCGCGCCTCCTCCTCGAGATTCCGAGCATAAA
ACGC

GMR28C04_F

GATTTCACTGGAACTAGGGGAGGGTAGTTCTGAAGCCATTCCCCGTTAAAT
TTG

GMR28C04_AscI_R

TGCTATTGAGTGGATGTGGGCGCGCCAGCGGCTAAAAATAATGCCAGTCG
ATCGGAG

GMR28B05_F

GATTTCACTGGAACTAGGGGCTGACTTCCAGGACTAGATGGGGATTTCTTT
G

GMR28B05_AscI_R

TGCTATTGAGTGGATGTGGGCGCGCCAGGGTAGTCGGGGTCGTTTATTTGG
AAGTTTG

SEG01_F

GATTTCACTGGAACTAGGGGCCCATCCGGGAAAAAGGGACAGATTTTAGC

SEG01_AscI_R

TGCTATTGAGTGGATGTGGGCGCGCCGTGATACGGATTTAAGAACTATTGT
GCGTTTC

GMR28E07_F

GATTTCACTGGAACTAGGGGGGGCATACCACAGTGAACTCAAAGCCTGGT
C

GMR28E07_AscI_R

TGCTATTGAGTGGATGTGGGCGCGCCTCTGGTGAAATGGCCTGACACTTGA
CGTGGC

SEG02_F

GATTTCACTGGAACTAGGGGGCCCATTGATCACCTATCCACCCTATCCCG

SEG02_AscI_R

TGCTATTGAGTGGATGTGGGCGCGCCGATCTCGAGTGATTGGAACATAGA
ACATAG

SEG03_F

GATTTCACTGGAACTAGGGGGGAACCCAGCATCCCAGTTGTAATCCCAGC
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Table 1 (Cont.)
GMR28F02.R
GIBSON

CTATTGAGTGGATGTGGGCGCGCCTGTAGCCATCTCAAGTCTAG

28G05.F ULTRA KIT
GIBSON

GAAAATGCTTGGATTTCACTGGAACTAGGGGGGCGCGCCGCATGGTTAAG
GAGGAAC

28G05.R ULTRA KIT
GIBSON

CCACGGAGAAAACTCCAAGTGCCTCCTCCTCGAGATTCCGAGCATAAAAC
G

28F02.F ULTRA KIT
GIBSON

CTCGGAATCTCGAGGAGGAGGCACTTGGAGTTTTCTCCGTGGACATGACAC

28F02.R ULTRA KIT
GIBSON

CATCATCATGTTGCTATTGAGTGGATGTGGGCGCGCCTGTAGCCATCTCAA
GTCTAG

Table2: Primers used for the CRISPR CAS-9 to delete robo2 putative enhancers
28Fo2.F gRNA

TATATAGGAAAGATATCCGGGTGAACTTCGTATTATTCCTCTTGTAAACG
TTTTAGAGCTAGAAATAGCAAG

28Fo2.R gRNA

ATTTTAACTTGCTATTTCTAGCTCTAAAACAGTGCATCTGTCTGTCATTCG
ACGTTAAATTGAAAATAGGTC

28Go5.F gRNA

TATATAGGAAAGATATCCGGGTGAACTTCGACAAATTGGTTCGCAAGAG
GTTTTAGAGCTAGAAATAGCAAG

28Go5.R gRNA

ATTTTAACTTGCTATTTCTAGCTCTAAAACACCTTACTGATCAACACATA
CGACGTTAAATTGAAAATAGGTC

CRISPR-GO5.F(811)

CTGACAGGGTCCTAAGATC

CRISPR-GO5.R(812)

GCGTTCACTGAACCTCCT

CRISPR-FO2.F(813)

GAGAGACCGACGACTGTCT

CRISPR-FO2.R(814)

CATGCCAACAACGCTCAGC

G05.N.F1

AGATTGGCTCGAAAGGCGAA

G05.N.R1

GAATCCACAATCCAGGGCCA

F02.N.F1

ATTGAATGCGGGAAGGGGAG

F02.N.R1

GTAATGAGAGCTTGCAGCGC

G05.N.F2

TCCCCTTCTTTCGACTGTGC

G05.N.R2

ACTAACAAAGCGGACTGGGG

F02.N.F2

AATGGAGCAGGCAGAGAACC
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Appendix 4: Fly crosses to make stocks

Appendix 4-1. The rescue of axon guidance decision of robo2 mutant background:
The GMR28G05::robo2 transgenic line is generated by BestGene Inc (Chino Hills, CA).
Injected (G0) individuals were crossed as adults to Sco/CyOwg to make a balanced stock.
The balanced stock female flies were crossed to robo2 mutant background
males(robo2135/CyOwg). F1 virgin females were then crossed to Sco/CyOwg males. F2
single 10 red-eyed males (positive to the transgene) were crossed individually to 3-5
virgin Sco/CyOwg females. After three days, the F2 males were removed from the
crosses and tested by PCR. F3 progeny from positive F2 crosses were used to generate
balanced stocks.
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Appendix 4-2. The rescue of axon guidance decision of robo2 mutant background:
The GMR28F02::robo2 is generated by BestGene Inc. (Chino Hills, CA). Injected (G0)
individuals were crossed as adults to Sco/CyOwg to make a balanced stock. The balanced
stock female flies were crossed to robo2 mutant background(robo2135/CyOwg). F1 virgin
females were then crossed to Sco/CyOwg males. F2 single 10 red-eyed males (positive to
the transgene) were crossed individually to 3-5 virgin Sco/CyOwg females. After three
days, the F2 males were removed from the crosses and tested by PCR. F3 progeny from
positive F2 crosses were used to generate balanced stocks.
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Appendix 4-3. The rescue of axon guidance decision of robo2 mutant background:
The GMR28F02::robo2 is generated by BestGene Inc. (Chino Hills, CA). Injected (G0)
individuals were crossed as adults to Sco/CyOwg to make a balanced stock. The balanced
stock female flies were crossed to robo2 mutant background(robo2123/CyOwg). F1 virgin
females were then crossed to Sco/CyOwg males. F2 single 10 red-eyed males (positive to
the transgene) were crossed individually to 3-5 virgin Sco/CyOwg females. After three
days, the F2 males were removed from the crosses and tested by PCR. F3 progeny from
positive F2 crosses were used to generate balanced stocks.
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Appendix 4-4: Driving robo2 expression by putative enhancers vs. robo2 native
enhancer. To check whether robo2 putative enhancers could drive robo2 expression as
strong as the native robo2 enhancer, (GMR28G05) or (GMR28F02)::HA- Robo2
transgenic lines were crossed with flies that were labeled with myc tag that represent the
native robo2 expression.
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Appendix 5: Plasmid construction maps. Each map is annotated with the vector name,
inserts (Janelia and non-Janelia fragments), the size of the vector, the promoter, epitope
tags, the coding sequence of the gene of interest, Antibiotic resistance, and restriction
enzyme locations.
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Adapted from https://www.addgene.org.
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Adapted from https://www.addgene.org.
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